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ABSTRACT 
It has been recognised for a number of years that patients with chronic skin disease 
experience a range of psychosocial difficulties. These include feelings of being 
stigmatised and the stresses of coping with a disease with an unpredictable course. To 
date, there have been few studies that examine the effects of stigmatisation caused by 
chronic skin disease. Researchers have suggested the need for a better understanding of 
how patients deal with the psychological aspects of skin diseases, as well as an 
understanding of the coping mechanisms used by individuals who feel stigmatised by 
their skin condition. Currently, no study makes comparisons between psychological 
difficulties in eczema and psoriasis patients. The current study examines the 
relationship between the stresses of having a chronic skin condition, feelings of 
stigmatisation and coping strategies adopted by patients with eczema and psoriasis. The 
participants were all dermatology patients, both inpatients and outpatients, who 
completed three measures exploring coping strategies, stigma experience and 
psychosocial impairment. Some participants attended for follow -up interview, providing 
a more personalised account of problems faced by eczema and psoriasis sufferers. It 
was hypothesised that participants who reported greater experience of stigma would 
relate a greater degree of psychosocial distress and show similar patterns in their coping 
strategies. These results are discussed with reference to current literature and 
suggestions made for future studies. 
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CHAPTER 1- INTRODUCTION 
INTRODUCTION 
1.0 GENERAL INTRODUCTION 
Skin conditions affect a large percentage of the population. It has been estimated that 
between 10 and 12 per cent of all General Practitioner consultations are in relation to 
skin disorders (Hunter, Savin & Dahl, 1989). The research literature suggests that skin 
is crucial to our sense of self and how we promote ourselves to the world. 
Consequently, skin disease can influence an individual's psychological well being. The 
majority of the research examining psychological factors in dermatology has focused on 
stress as a cause and /or consequence of skin disease. Recent studies have become more 
interested in the impact of skin disease on quality of life and to a lesser extent on the 
experience of being stigmatised. 
In the introduction to this study, the opportunity will be taken to explore general issues 
relating to the skin and specific factors regarding eczema and psoriasis. The relationship 
between these conditions with experience of stigma, coping strategies and quality of life 
will also be examined. In addition, current literature relating to psychological 
intervention in skin disease will be discussed. 
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1.1. PSYCHOLOGY AND THE SKIN 
1.1.1 Emotional Factors 
Skin is the largest organ in the body weighing approximately four kilograms and 
covering an area of around two square metres and acts as the interface between humans 
and their environment (Forsdyke and Watts, 1994). As the organ of touch, temperature 
and pain sensation, and as an erogenous zone, the skin has great psychological 
importance (Savin and Cotterill, 1992). As James (1995) notes, it is evident that 
psychological factors are associated with changes in the skin: emotional expression 
involves both sensory and visible changes in the skin. Consequently, as the skin reacts 
directly upon emotional stimuli, dermatological conditions frequently involve a somatic 
dimension (Van Moffaert, 1992) and those with skin disorders carry with them 
disportionately heavy psychological punishment. As a means of communication, the 
skin can be very powerful. Gupta and Voorhees (1990) suggest that an individual's skin 
can communicate emotional distress, and underlying the dermatological problem, there 
may exist a full range of personal and family problems. In terms of management of 
dermatological conditions, it has been estimated that for at least one third of 
dermatology patients, emotional factors precipitate and /or maintain skin conditions (Koo 
& Pham, 1992). Although the prevalence of psychological disorders in dermatology is 
unknown, Hughes, Barraclough, Hamblin and White (1983) document that dermatology 
in- patients are known to have a higher prevalence of psychiatric disorders than general 




1.1.2 Body Image 
It is well recognised that our skin is integral in the development of body image, 
promoting a sense of well being and is an important contributor to social reputation 
(Kreugar, 1989; Jobling, 1992). In many different cultures those with a skin condition 
may experience a sense of shame and guilt and anticipate the threat of social rejection 
(Jobling, 1992). In reference to psoriasis, Ginsburg (1996) suggests that one of the most 
distressing aspects of the disease is how it attacks the sense of self and an individual's 
ability to accept themselves as a worthwhile human being. She goes on to discuss that if 
the skin is seen as abnormal and defective to the outsider then it seems to apply that the 
human being inside the skin is also defective and abnormal. Given the emphasis in 
society today on health and external beauty, skin disease can make a person stand out 
while other illnesses are not as visible. Koblenzer (1997) has reviewed this further with 
particular reference to women. She thinks that the emphasis on external perfection and 
the power of the media to promote perfection creates huge difficulties for adolescent 
females as they adjust to their body image. This is immeasurably greater for the girl 
without perfect skin, hair or figure. Gupta, Kirkby, Schork, Gorr, Ellis and Voorhees 
(1989) note that 58 per cent of psoriasis patients develop the condition before age thirty 
and suggest that a significant number face cosmetic disfigurement at a stage when they 
may be most self -conscious about their appearance. Others report anecdotal evidence 
that the psychological impact of having a skin condition is more evident when the 
disorder occurs during this developmentally critical period. This is a stage when 
individuals are seeking to establish and maintain a good reputation and position in 
social, sexual and economic competition (Gupta, Gupta and Haberman, 1987 and 
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Jobling, 1992). As a consequence of this cosmetic disfigurement and social stigma, a 
vicious circle is created; the individual may develop disease -related stress reaction that 
in turn exacerbates the skin condition adversely affecting the course of the disease. 
1.1.3 Psychological Problems Associated with Skin 
The scope for psychological difficulties, when there is some degree of skin disease or 
disfigurement, is great. For centuries, the prevailing view in medicine has been that 
psychological factors have been important as the cause of skin disease. It is only during 
the past fifty years that the opposite view, that skin disease cause psychological 
problems and disability, has been accepted (Finlay and Ryan, 1996). Despite this, much 
of the early literature was concerned with the role of personality traits, which were 
thought to predispose individuals to skin complaints. James (1995) suggests that many 
of these early studies have created misconceptions among dermatologists about the role 
of psychological factors in skin disease and consequently many introductory textbooks 
lend little credence to the area of psychodermatology. 
As the skin is exposed to view, any skin disease readily elicits reactions from the 
patients' environment. Furthermore, the easy accessibility of the skin allows individuals 
to interact directly with their skin lesions, so that behavioural factors such as touching, 
scratching, exaggeration or neglect of the necessary skin care are likely to complicate or 
create further lesions (Van Moffaert, 1992). As skin conditions are often visible, this 
carries the connotation of contagion or a lack of hygiene and may cause the individual to 
feel ostracised. The resulting self -depreciative feelings may lead to social fear and 
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shame and further psychological distress. It is important to remember that the exact 
impact of a skin condition is dependent on individual experiences. Although many 
people will react differently to the same condition, there is some evidence that certain 
skin complaints may result in people experiencing a common cluster of problems 
(James, 1995). 
Following interviews with 100 individuals about the impact a skin condition had on their 
lives, Jowett and Ryan (1985) concluded that a cosmetically disfiguring condition can 
result in social disapproval and increased self -consciousness impinging on employment, 
social and personal relationships. In skin conditions such as eczema and psoriasis, both 
non -specific emotional stress factors and specific life events can trigger a relapse, affect 
the onset and duration of symptoms, and affect patient compliance (Van Moffaert, 
1992). Cotterill and Cuncliffe (1997) suggest that males and females with facial 
disfigurement may be a high -risk group for suicide and review a number of case studies 
of suicides in dermatology patients. 
Symptoms found in dermatological conditions are frequently associated with 
psychological problems. Pruritus (itching) is defined as a sensation that provokes the 
desire to scratch. This is the most common symptom of dermatological disease. In 
psoriasis, pruritus may be a symptom in over 70 per cent of cases (Gupta and Voorhees, 
1990). Depression is frequently reported to be prevalent in individuals reporting 
pruritus. A study by Sheehan -Dare, Henderson and Cotterill (1990) reported depressive 
symptomatology rates of 32.4 per cent in generalised pruritus sufferers compared to 13.2 
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per cent of controls. The authors concluded that it was difficult to determine whether 
pruritus is a symptom of depression or whether the higher incidence merely reflected a 
reaction to such a persistent and distressing symptom. Other researchers have suggested 
that a depressed clinical state may reduce the threshold for pruritus. In a study of self 
rating scores of pruritus, Gupta, Gupta, Schork and Ellis, (1994), found individuals with 
either psoriasis, eczema or urticaria showed a positive correlation between self rating 
indices of pruritus and scores on the Carroll Rating Scale for Depression. Other studies 
have examined the link between pruritus in atopic eczema and mental stress (Jordan and 
Whitlock, 1974). This is a potential area for further research to examining the role of 
psychoimmunological factors. Authors such as Folks and Kinney (1992) have noted that 
other syndromes, known to be similarly influenced by psychophysiological factors, such 
as migraine and irritable bowel syndrome, are frequently reported to co -exist in patients 
with dermatoses. They propose revision of the Diagnostic and Statistical Manual 
category of psychological factors affecting physical conditions, in order to improve the 
quality and depth of future investigations. 
1.1.4 Psychological Classification of Skin Disease 
Several authors have suggested classification of psychodermatological disease 
(Koblenzer, 1988; 1997) and most have defined three broad categories. The first is 
related to psychiatric disorders that manifest in the skin such as dermatitis artefacta, 
parasitosis, body dysmorphic disorder and obsessional habits and concerns about the 
skin. The second category relates to conditions with a psychogenic factor such as 
urticaria, pruritus, flushing reactions and alopecia areata. The final category relates to 
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skin conditions which are probably dependent on genetic or environmental factors but 
whose course is often significantly affected by psychological factors. This category 
includes conditions such as psoriasis, atopic dermatitis, acne vulgaris and potentially the 
whole spectrum of clinical dermatological conditions. 
1.1.5. Summary 
Looking at the available literature it is clear that skin plays a crucial role in 
psychological development and functioning. When an individual is afflicted with a skin 
condition, the potential for psychological distress appears great. It is Koblenzer's (1988, 
1997) final category of skin disease which is examined in this study, in particular 
eczema and psoriasis. Both these conditions are described with reference to 
psychological functioning in the following sections. 
1.2 PSORIASIS 
1.2.1 What is Psoriasis? 
Until it was identified as a distinct disease in 1841, psoriasis was described as a variant 
of leprosy and regarded as contagious. Psoriasis has an unpredictable course and can 
first manifest at any age with a varying duration from a few weeks to a whole lifetime. 
The disease is characterised by red raised lesions covered with silvery scales (Taylor and 
Buckwalter, 1988). These psoriatic lesions are produced due to acceleration of mitosis 
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which leads to an accumulation of cells at the skins surface producing a scaly 
appearance. Onset of the disease may show a bimodal distribution, peaking at 21 years 
in males and 16 years in females, and then again for males at 57 years and 60 years in 
females (Klaber, 1992). There are no sex differences in the occurrence of psoriasis. 
Early onset of the disease and a positive family history predict a poorer prognosis (de 
Jong, 1997). Little is known about why psoriasis develops, but some triggering factors 
have been identified such as infections, in particular streptococcal throat infections, 
endocrine factors, hypocalcemia, cold and damp climate, various drugs and psychogenic 
stress. In a large study by Park and Youn (1998), examining factors that influenced 
psoriasis, results indicated that summer; sunlight and pregnancy were favourable factors 
while effects of winter and stress produced adverse responses in the majority of subjects. 
Psoriasis can manifest in several different forms and can appear almost anywhere on the 
body. In its most acute state, psoriasis can be life threatening. Psoriasis sufferers may 
also develop photosensitivity and psoriatic anthropathy, a form of arthritis (Klaber, 
1992). Although modern medicine and techniques offer symptom management for the 
sufferer, there is no specific cure for the disorder. 
1.2.2 Medical Treatment of Psoriasis 
The relapsing nature and wide range of clinical manifestations of psoriasis leads to many 
therapeutic problems. Treatment regimes often need to be tailor made for each patient 
with allowances made for the individuals psychological and physical reactions to their 
skin condition (Judge and Griffths, 1992). The most common treatments often involve 
the use of greasy, pungent ointments such as coal tar. Jobling (1992) argues that the 
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patient is soiled by the existence of the disease and the nature of the treatment reinforces 
and amplifies the disabling nature of the skin condition. More recent hospital treatments 
such as light therapy and oral medication have many side effects. Light therapy 
promised much when it was introduced, but the negative side effects, as well as the 
benefits, may affect psychological well being. The pronounced tan, which is a side 
effect of the treatment, can lead to unwanted questioning and may be viewed by others 
as vain (Jobling, 1992). This may be particularly marked when patients receive 
treatment in the winter months in the light of public health warnings about avoiding the 
risks of skin cancer. Jobling (1992) also comments on the unrealistic expectation of 
many individuals that light therapy is a cure for psoriasis. This undoubtedly leads to 
disappointment and potentially heightens the likelihood of anxiety and depression. 
1.2.3 Life Stress in the Onset and Exacerbation of Psoriasis 
Psoriasis is not only influenced by stress factors but can also serve as a stressor in itself 
and can negatively influence the well being of the patient (Judge and Griffiths, 1992). 
There has been a vast amount of research examining the role of stress in the onset and 
exacerbation of psoriasis. Al'Abadie, Kent and Gawkrodger (1994), in a review of the 
literature, estimated that the proportion of psoriatic patients whose disease is affected by 
stress varies between 40 and 80 per cent. These figures are dependent on how stress is 
defined, whether acute or chronic, and how it is measured, generally by self -report or on 
standardised checklists. The study by Al' Abadie et al. (1994) asked a group of 
dermatology patients to rate if their skin condition first developed after an important 
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stressful event and how soon after this event it first manifested. Although the sample 
size was small, they concluded that stress was a more significant factor in the onset and 
progression of psoriasis in comparison with other skin diseases. Other studies, such as 
Invernizzi, Gala, Bovio, Conte, Manca, Polenghi and Russo (1988), have looked at the 
role of stress in the onset of psoriasis by comparing the number of psoriasis patients who 
experienced a stressful life event in the past year, against a group of controls. Over 75 
per cent of the psoriasis patients reported a significant life event compared to 23 per cent 
of the controls. For a majority of the psoriasis patients, symptoms appeared within one 
month of the event. General research examining the role of stress in psoriasis has 
clustered in three broad categories (Ginsburg, 1995). Initial research tended to be 
mainly based on anecdotal evidence, which was followed by large -scale epidemiological 
questionnaires. After this, research based on life event methodology emerged and more 
recently, work has concentrated on the combination of life event with standardised 
questionnaires. Ginsburg (1995) has suggested that the life event may not be the trigger 
per se, but if a stressful life event takes time and energy, an individual may not be able 
to maintain their treatment regime and thus trigger a flare -up in their skin condition. As 
psoriasis patients frequently report improvements in their skin during summer months, 
the particular time of year and exposure to sunlight may be a confounding factor, if 
patients are included in a study at different times. Types of life events identified in these 
studies also vary considerably. What one individual views as a single major event may 
be a more frequent minor occurrence for others. Due to the problems in defining stress 
and the methodological difficulties in these studies, it is difficult to draw any conclusion, 
especially when no longitudinal studies have been conducted (Ginsburg, 1995). Flaws 
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in methodology are a major criticism of the extensive literature examining stress and 
psoriasis. Park and Youn (1998) suggest the main criticisms of the current literature is 
that the studies are subjective, do not exclude observer bias and that they are largely 
uncontrolled. 
Gupta et al. (1989) looked at individual differences in responses to stressful situations 
for psoriasis patients. One hundred and twenty -seven consecutive outpatients were 
asked to self -rate stressful situations frequently making their psoriasis worse. From this, 
subjects were defined as high or low stress reactors. On completion of an extensive 
psychometric battery, results indicated that high stress reactors tended to be younger 
than the low stress reactors. There was, however, no significant difference between the 
mean duration of psoriasis for either group. High stress reactors reported experiencing 
more disease -related stress than the low stress reactors. It was also noted that the high 
stress reactors had greater psoriasis severity on their scalp, face, neck, forearms, hands 
and genital regions. Gupta et al. (1989) label these areas as emotionally charged. 
Interestingly, there was no significant difference between overall severity of psoriasis 
between the high and low stress reactors. This is in contrast to the study by Park and 
Youn (1998) which found those with more extensive psoriasis, not related to any 
particular anatomical area, regarded their psoriasis to be more stress related. In 
conclusion, Gupta et al. (1989) suggest that having psoriasis in emotive areas increases 
the risk of an individual experiencing social stigma and thus increases the vulnerability 
to the stress associated with this. Consequently, minor long -term stresses associated 
with having psoriasis may have a greater impact on the disease than acute and generally 
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short-lived major life events. Gupta et al. (1989) suggest this may explain the varying 
and often conflicting research examining the relationship between stress and psoriasis. 
1.2.4 Beliefs about Psoriasis and the Role of Stress. 
With such a reliance on self -report measures, it is important to consider the individuals 
prior beliefs about the cause of the disease and to acknowledge the considerable 
variation in how individuals react to stressful experiences. Fortune, Richards, Main and 
Griffiths (1998) undertook a detailed study of 162 patients with psoriasis to determine 
what psoriasis patients believe about their skin condition using the Illness Perception 
Questionnaire. Results from this study indicated that 60 per cent of subjects believed 
that stress was a major factor in the onset of their condition. Where there was a strong 
family history of psoriasis subjects were more likely to attribute their skin condition to 
genetic factors, particularly if their condition developed before age forty. On the whole, 
females were more likely to attribute the cause and exacerbation of their psoriasis to 
their own behaviour. In the same study, the majority of psoriatic patients indicated that 
the condition had a major impact on their lives and the ways in which they viewed 
themselves. Again females reported that psoriasis had a greater impact on their lives. In 
conclusion, Fortune et al. (1998) suggest that the patients beliefs about their skin 
condition may have little to do with how severe their psoriasis is, but very much more to 
do with the meaning they ascribe to the unpredictable course of their condition. These 
results confirm the view that individuals often respond to the difficulties of a chronic 
illness by constructing their own common sense model of their condition (Weinman, 
Petrie, Moss -Morris and Home, 1996). 
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1.2.5 Anxiety, Depression and Anger in Psoriasis Patients 
In a comprehensive review of the psychosocial impact of psoriasis, Wahl (1997) suggest 
that exposure to the physical features of psoriasis including itching, scaling and pain, has 
significant physical, emotional and social consequences. In a study by Fried, Friedman 
and Paradis (1995), more than half the outpatients who participated were rated as having 
moderate to extreme levels of anxiety, depression and anger. These results were not 
restricted to periods during skin flare -ups, with high scores reported during periods of 
remission. Studies of inpatients have found subjects to be more severely affected 
(Polenghi, Moloniari, Gala, Guzzi, Garutti and Finzi, 1994; Mazzetti, Mozzette and 
Soavi, 1994). Hughes et al. (1983) found that 33 per cent of dermatology inpatients and 
15 per cent of outpatients had high scores on standard measures of depression. 
Symptoms of psoriasis, such as disfigurement, stigma and the inconvenience associated 
with the disease, are implicated in the onset of the depression. 
1.2.6 Disability in a Non -treatment Seeking Population 
Prevalence of psoriasis is thought to be about 1 -2 per cent of the population in Britain. 
However, only 3 per cent of this group see a dermatologist, 17 per cent are treated by 
their general practitioner alone and the other 80 per cent do not consult any medical 
practitioner (Hunter et al. 1989). As the majority of studies focus on dermatology in- 
patients and outpatients, O'Neill and Kelly (1996) set up a study to examine those 
psoriasis patients who do not seek hospital consultations. This study compared the 
general health of people with psoriasis with the general population and evaluated the 
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Psoriasis Disability Index as a measure of disability in a community -based population. 
Results suggested that people with psoriasis in the general population suffer serious 
disability in many aspects of daily life, in comparison with controls. Although, the mean 
scores on the Psoriasis Disability Index were significantly less than in a hospital based 
study, there was a significant negative correlation with all variables on the General 
Health Questionnaire and the Psoriasis Disability Index. The results suggest that people 
with psoriasis perceive themselves to be less healthy than the general population and 
consequently general practitioners should be wary of underestimating the degree of 
distress a skin condition such as psoriasis can cause. 
1.2.7 Summary 
From this brief summary, examining psoriasis and psychological influence, it is clear 
that a high percentage of individuals experience psychological difficulties as a 
consequence of having psoriasis. Although the research is not clear about the nature and 
degree of stress required to impact on psoriasis, the evidence indicates both treatment 
and non -treatment seeking populations are affected. The following section will discuss 




1.3.1 What is Eczema? 
The terms dermatitis and eczema are used interchangeably (Docherty, 1987). Often they 
are preceded by ` aopic', but all refer to the same condition. As with psoriasis, the 
aetiology of eczema remains virtually unknown. Eczema is often described as a disease 
of delayed type allergy with resulting clinical features on the skin. Although there is 
strong evidence for genetic factors, there is a growing body of evidence that indicates a 
multi -factorial aetiology that includes psychological factors (Ehlers, Stangier and Gieler, 
1995; Shirta, Nishitani, Fujino, Takano and Kiriike, 1996). Prevalence figures are quite 
varied; Faulstitch and Williamson (1985) report that between 7 and 24 individuals per 
1000 experience symptoms of eczema, whereas the National Eczema Society (1997) 
report prevalence rates of 2 to 10 per cent in adults and 5 to 15 per cent in school age 
children. Atopic eczema is the most common variant of the disease, and although it is 
mainly a disease of childhood, it will continue into adulthood for approximately 10 per 
cent of subjects (Herd, Tidman, Ruta and Hunter, 1997). In adulthood, eczema is 
characterised by dry and lichenified eruptions with scaling and erythema (Faulstich and 
Williamson 1985). As eczema is usually accompanied by a severe itch - scratch cycle, 
many sufferers report sleep disturbances, difficulties in concentrating and irritability, 
which aggravates their symptoms creating a vicious circle. 
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1.3.2 Medical Treatment of Eczema 
Steroid hormones, anti -allergic and anti -pururitic agents are generally used to treat the 
disease. Some patients worry about the side effects which may result from treatment 
and the symptoms, which may restrict daily life (Shirta et al. 1996). In addition eczema 
patients are often advised to avoid certain chemical products such as biological washing 
powders, or soaps which may cause irritation to the skin. Due to the itch -scratch cycle, 
secondary infection is a common problem in eczema and is usually treated with 
antibiotics. As with psoriasis, many of the treatments available are time consuming to 
administer, unpleasant and messy, frequently with unwanted side effects. This clearly 
has implications for psychological wellbeing, particularly if the disease is chronic. 
1.3.3 Psychological Factors in Eczema 
Among skin disorders with a suspected somatic component, eczema is the condition 
most frequently cited (Faulstich and Williamson, 1985). However, reports describing 
the psychological state of patients with eczema are quite limited and generally tend to 
focus on one particular symptom, usually anxiety or depression (Hashiro and Okumara, 
1997). This is a considerable contrast to the expansive literature examining 
psychological factors in psoriasis, as reviewed above. Existing studies mainly consist of 
clinical case examples and theoretical speculation, rather than systematic empirical and 
experimental observation (Keller, Zalewski, Carmody and Livingston, 1996). It may be 
the case that eczema has traditionally been viewed as a disease of childhood. 
Consequently, the effects of having eczema in adulthood have largely been ignored. 
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1.3.4 Anxiety and Depression in Eczema 
The majority of studies find that both children and adults suffering from eczema have a 
higher anxiety level than non - sufferers (Linnet and Jemec, 1999). Hashiro and Okumura 
(1997) examined both anxiety and depression with somatic symptoms in a comparison 
between a group of patients with atopic dermatitis and controls, and between different 
degrees of severity. They found the experimental group to have greater depression 
ratings and to be more prone to somatic symptoms than controls. In relation to anxiety, 
no differences were found between the experimental and control groups. These results 
contradict with earlier findings by Ginsburg and Link (1993), that reported atopic 
dermatitis patients as frequently presenting as chronically anxious. Differences may be 
explained by the different experimental populations, adults in the Ginsburg study and 
adolescents in the Hashiro and Okumura study. Additionally cultural variations between 
the populations studied may account for differences found. The authors further 
examined the role of psychological state in atopic dermatitis, by comparison of 
psychological measures with biological/ immunological markers (Hashiro and Okumura, 
1998). The results suggested that patients with moderate to severe skin conditions scored 
higher on psychological measures and showed lower biological markers than controls. 
The authors suggest that these results confirm the possible role of psychoimmunological 
factors in skin disorders. 
In a more recent study, Linnet and Jemec (1999) examined the hypotheses that eczema 
patients would have higher anxiety and a lower quality of life than a control group. As 
the literature has often led to contrasting results, as discussed above, the authors 
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examined the possible relationship between eczema severity and particular components 
of anxiety. Subjects in this study were all adults. Results supported the hypotheses that 
eczema patients had higher anxiety scores and lower quality of life than controls. 
Severity of eczema was found to show greater relationship to items relating to care and 
management on quality of life measure, than on items relating to psychological factors. 
Consequently, the authors conclude that psychological assessment is especially 
important in differentiating the patients in need of psychological treatment, whereas 
dermatological treatment may help in reducing general anxiety levels. 
Shirta et al. (1996) studied 64 outpatients with severe atopic dermatitis using the 
General Health Questionnaire and tested subjects pre and post treatment, in a 
comparison with healthy controls. Results indicated that patients were markedly 
disturbed in all areas measured before treatment; somatic symptoms, anxiety and worry, 
social dysfunction and despondency, and depressed mood. Scores were significantly 
reduced on all scales following improvement in skin condition. The authors suggested 
that psychological support for patients with atopic dermatitis should become a crucial 
part of treatment. 
1.3.5 Disability in a Non -Treatment Seeking Population 
Although many eczema patients, as with those with psoriasis, are treated in a hospital 
setting there is a large non -treatment seeking population with symptoms of eczema. 
Keller et al. (1996) looked at this non -treatment seeking population as part of larger 
study of Vietnam veterans. In a comparison of eczema sufferers with a group of tinea 
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sufferers (a fungal skin infection thought to be unrelated to psychological factors) and a 
control group, no significant difference were reported in terms of prevalence of anxiety, 
depression, hostility or levels of social support . Overall anxiety was reported in only 16 
per cent of subjects compared to estimates of 26 to 63 per cent in previous studies. 
Depression rates are also considerably lower in this study. The authors suggest that 
subjects who seek treatment may be seeking relief from psychological symptoms as 
much as, or more than, the dermatological symptoms. Methodologically it is difficult to 
draw any firm conclusions from this study given the restrictive population of male 
veterans' aged 40 to 50. Further research is required to further examine the differences 
between treatment seeking and non -treatment seeking individuals in a more 
representative population. 
1.3.6. Summary 
Although research examining individuals with eczema has not been as extensive as in 
psoriasis, the same issues are clearly applicable to both. The causes of stress and other 
psychological difficulties in individuals with eczema and psoriasis are often associated 




1.4 EXPERIENCE OF STIGMATISATION 
1.4.1 Definition 
Ginsburg and Link (1989) define stigma as a biologic and social mark, that sets a person 
off from others, is discrediting and disrupts interactions with others. In relation to social 
stigma, Gupta, Gupta and Watteel (1998) suggest the term implies a mark of social 
disgrace, which manifests due to society's unwillingness to accept or approve of 
individuals with skin disease. 
1.4.2 Background 
Although there is a wealth of research exploring the effects of stigmatisation in other 
medical and psychological complaints such as epilepsy, Human Immunodeficiency 
Virus and mental illness, research in dermatology is limited. Ginsburg and Link (1989) 
attribute this lack of research to the conflicting views between patients and their 
dermatologists. In a study by Baughman and Sobel (1970), comparing patient and 
dermatologist views of the consequences of having a skin condition, patients ranked 
embarrassment over their appearance as the most significant consequence, whilst 
dermatologists ranked this as the least important outcome. There has been a growing 
awareness of the issue of stigma in dermatology over the past thirty years, but there 
continues to be a lack of systematic research in the area. Although frequently mentioned 
in relation to quality of life and consequences of having a skin disease, there have been 
few studies which specifically address anticipation of and actual experience of being 
21 
INTRODUCTION 
stigmatised. As mentioned earlier (section 1.1.2), many individuals will develop their 
skin condition before they are thirty. As the visibility of skin conditions can be a crucial 
factor in an individuals psychosocial development, it is likely that actual or anticipated 
experience of stigma will also play a crucial role in this psychosocial development. 
1.4.3 Experience of Stigma in Dermatological Conditions 
Literature examining stigma experience in the two skin conditions, eczema and psoriasis 
explored in this study, is limited. The majority of the research has focused on psoriasis 
and has been carried out by Ginsburg and Link (1989; 1993) in the United States. In the 
development of their questionnaire exploring stigma experience in psoriasis patients, 
100 adults both inpatients and outpatients participated in their study (Ginsburg and Link, 
1989). The research was centred on the development of a 33 -item questionnaire 
measure. The data collected suggested there are six dimensions associated with stigma. 
These are sensitivity to the opinion of others, anticipation of rejection, feelings of being 
flawed, guilt and shame, secretiveness, and positive feelings. Results concluded that 
many individuals do report feeling stigmatised by their skin condition but that this is not 
a universal experience. In relation to the course of the individuals skin disease and 
stigma experience, three main points emerge from this research. These are outlined 
below. 
1. Being older at the onset of psoriasis protects against anticipating rejection, feeling 
sensitive to the opinions of others and feelings of shame and guilt. 
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2. The longer an individual has experienced the illness the more likely they are to show 
less guilt, shame and secretiveness. 
3. Findings clearly indicated that those with an early onset tend to show greater 
vulnerability to reporting stigmatisation. 
Being secretive was identified, by Ginsburg and Link (1993), to be one of the most 
important components of daily experience of an individual with psoriasis. Evidence of 
wearing concealing clothing and avoidance of situations where skin lesions could be 
disclosed is particularly evident. This secretiveness did appear to be less apparent in the 
participants who were currently being treated as inpatients. The authors suggest this 
may be related to the environment of a ward setting where everyone has a skin condition 
and consequently inpatients may feel more comfortable about revealing their skin 
condition. It may have been expected that individuals with greater severity of psoriasis 
would report greater stigma experience. Surprisingly, this study reported extent of 
bleeding as the strongest predictor of feeling stigmatised. This is a perhaps unexpected 
result as bleeding is not usually a significant factor in psoriasis. 
In a more detailed report of this study Ginsburg and Link (1993) focused on two 
dimensions of the stigma questionnaire, sensitivity to opinion of others and anticipation 
of rejection. Results indicated that there was a high correlation between feeling rejected 
due to psoriasis and problems at work, seeking professional help and alcohol 
consumption. In conclusion, the authors suggest these results reflect observations that 
people may act out their distress without being consciously aware of their feelings. 
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They also anecdotally report that rejection experiences are not always overt and that 
averting a glance or avoiding hand -shakes can be just as devastating as outward acts of 
rejection. Unfortunately, this study focused on direct acts of rejection such as being 
asked to leave a public situation, such as a swimming pool. As a consequence of such 
rejection experiences, Ginsburg and Link (1993) postulate that patients who anxiously 
anticipate rejection will very often avoid interpersonal situations or public places where 
they may be stigmatised. In turn, a vicious circle may develop with anticipation of 
rejection and avoidance of social situations influencing the course and severity of their 
skin condition. Consequently Ginsburg and Link (1989, 1993) emphasise the 
importance of provision of psychotherapy or support groups as a means of helping 
individuals cope with the stigma experience. 
In a more recent study Gupta, Gupta and Wattell (1998), studied the stigma experience, 
by examining the deprivation of social touch that validates social rejection of patients 
with psoriasis. In this inpatient study, 137 consecutive patients were classified as 
belonging either to the stigmatised group or non -stigmatised control group on the basis 
of a question asking if they had experienced a situation in the past month where 
someone had overtly avoided touching them. Clearly this also misses individuals who 
may have experienced more subtle forms of social stigma such as avoided glances, 
particularly as those reporting no experiences in past month were used as the control 
group. Twenty -six per cent of participants in this study reported an episode in the past 
month where someone had made an obvious effort not to touch them. As mentioned 
earlier, inpatients in the Ginsburg and Link (1989) study reported less stigma 
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experience, consequently inclusion of an outpatient group in this study may have yielded 
a higher percentage of individuals reporting stigma experience. It was notable in this 
study that all but one of the subjects in the stigmatised group had one part of their body 
affected with psoriasis that was visible in social interactions. However, those reporting 
deprivation of social touch did not necessarily have psoriasis affecting a body region that 
is frequently touched in social interactions, such as hands or forearms. Of the 
psychological measures the comparing stigmatised group with the non -stigmatised 
group, depression scores were significantly higher in the stigmatised group. This is 
particularly important, given that a previous study (Gupta and Gupta, 1998) reported 
psoriasis to be associated with greater incidence of suicide. 
1.4.4 Measurement of Stigmatisation 
General measurement of stigma experience is limited to small studies and questionnaires 
developed for use with restricted subject groups. As described above, Ginsburg and 
Link (1989) developed a questionnaire for patients with psoriasis based on concepts 
relating to the nature of stigma and clinical experience of the researchers. As mentioned 
previously, the aim was to elicit feelings about expectations of rejection, experiences of 
discrimination, alienation, weakness, secretiveness, shame and guilt, and uncleanness. 
Interestingly, an additional factor, not predicted, related to positive attitudes. This factor 
proved difficult to interpret, as high despair on one factor did not preclude individuals 
reporting positive feelings about their skin condition. 
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To redress the sole focus on stigma experience in psoriasis, Scmid -Ott, Jaeger, 
Kuensebeck, Ott and Lamprecht (1996) developed the Ginsburg and Link questionnaire 
for use in a variety of dermatological conditions. Existing questions were adapted and a 
further 15 items were added. These items were based on previous research examining 
general stigma experience (Jones, Farima, Hastorf, Markus, Miller and Scott, 1984). 
Analysis of these items on patients with eczema, psoriasis and acne led to five distinct 
factors being identified, including the positive factor missed in previous research. These 
were self - esteem, retreat, rejection, composure (positive feelings) and concealment. 
Consequently, this measure can be administered to individuals with a number of 
differing skin complaints and allows comparisons across different symptomatologies. 
To date there has been no study that examines differences in stigma experience between 
various skin conditions. 
1.4.5 Summary 
Research in the area of stigmatisation in relation to skin disorders is still in its infancy. 
The evidence clearly indicates that being stigmatised is a common factor for individuals 
with eczema and psoriasis. Experience of stigma is often discussed in relation to quality 
of life and this will be reviewed later. Ginsburg and Link (1989;1993) suggest that 
further research is required to understand the coping mechanisms of individuals, who 
feel stigmatised by their skin condition. The issue of coping in general and in relation 





There has been a wealth of research over the past thirty years examining how individuals 
cope with stressful situations as well as development of theories that adequately explain 
this. To date there has been little agreement over the conceptualisation and 
measurement of coping strategies (Aldwin and Revenson, 1987). Weinman, Wright and 
Johnston (1995) suggest there are two main areas of interest in relation to how 
individuals cope in stressful situations. The first stems from attempts to identify and 
explain the links between stress and health and the second from health psychology's 
attempts to understand the impact of illness. Research on coping indicates that levels of 
stress experienced depend on the way an individual copes with the different demands of 
the illness. 
1.5.2. Definitions 
Much of the research to date has focused on Lazurus's (1966) research into stress and 
coping. Lazarus and his co- researchers define coping as a person's constantly changing 
cognitive and behavioural efforts to manage specific external or internal demands that 
are appraised as taxing or exceeding the person's resources (Folkman, Lazarus, Dunkell- 
Schetter, DeLongis and Gruen, 1986). An individual's cognitive understanding of a 
particular encounter is appraised on two levels; 
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1. Primary appraisal is when a person evaluates whether they have anything at stake in 
the encounter 
2. Secondary appraisal occurs when the individual evaluates, what if anything, can be 
done to overcome or prevent harm or to improve prospects for benefit. 
Coping is the process of executing the response to primary and secondary appraisal. 
In addition, coping has two widely recognised functions. Emotion -focused coping 
regulates stressful emotions, whereas problem- focused coping alters the persons 
environment in relation to whatever is causing distress. Consequently, as defined by 
Lazarus (1966), coping has three features. Firstly that it is process- orientated by 
focusing on what the person actually thinks and does in a specific encounter. Secondly 
it is contextual, in that it is influenced by the person's appraisal of the actual demands of 
the situation and their appraisal of resources available for managing these demands. 
Lastly, no assumptions are made about what constitutes good or bad coping, it is simply 
defined as a person's effort to manage demands faced. 
1.5.2 Measurement of Coping 
One of the most widely used instruments to measure coping is the Ways of Coping 
Checklist designed and then revised by Folkman and colleagues (Folkman and Lazarus, 
1980; Folkman, Lazarus, Dunkel- Schetter, DeLongis and Gruen, 1986). This is a 51- 
item questionnaire which assess coping responses a person selects to manage a particular 
stressful situation. Two problem focused subscales were reported (planning problem 
solving and seeking social support). Six emotion focused subscales were also reported 
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(confrontative coping, distancing, self -controlling, accepting responsibilities, escape 
avoidance and positive appraisal). The Ways of Coping Checklist has been frequently 
modified for use with a variety of different medical conditions. Many of these have not 
reported the same factor structure (Weinman et al., 1995). Consequently, Blanchard and 
Harper (1996) advise caution in the use of these measures, as many of the potential 
benefits have been lost through modifications to psychometric properties. These losses 
include the lack of empirical evidence for coping sub -scales, and the various scaling 
methods used leads to limitations in comparisons between studies. 
Carver, Scheier and Weintraub (1989) suggested that Folkman and Lazarus's (1980) 
Ways of Coping Checklist is too simplistic in its measurement of coping strategies. 
Carver and Scheier (1994) suggest that differentiating between emotion- focused coping 
and problem- focused coping, as defined by Folkman and Lazarus (1980), is easy in 
principle but in reality there is often a considerable degree of overlap. The development 
of the COPE was an attempt to overcome some of the ambiguity of previous measures. 
In the development of the COPE, Carver el al. (1989) tested 978 subjects and results 
identified 13 distinct coping styles. The first of these styles is active coping. The 
authors suggest that this is very similar to the term problem focused coping, as described 
by Folkman and Lazarus (1980). Other problem- focused styles identified were 
planning, suppression of competing activities, restraint coping and seeking social 
support for instrumental reasons (e.g. seeking advice). Carver el al. (1989) suggest these 
additional problem- focused styles mainly function at the primary and secondary levels 
of appraisal, whereas active coping is the process of executing the response. Seeking 
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social support for emotional reasons is termed as emotion -focused coping but the 
authors acknowledge that thus often co- occurs with the seeking of social support for 
instrumental reasons. Previous research (Folkman and Lazarus, 1980 and Vitalino, 
Russo, Carr, Maiuro and Becker, 1985) has suggested that other emotion -focused coping 
may be maladaptive. Carver et al. (1989) describe a further emotion -focused coping 
style, focusing on and venting of emotions. They suggest that this strategy impedes 
adjustment to a situation. Two other dysfunctional styles are identified on the COPE, 
behavioural disengagement and mental disengagement. Other sub -scales on the COPE 
measure positive reinterpretation and growth, denial and acceptance (the opposite of 
denial). The final sub -scale on the COPE measures turning to religion as a coping 
strategy. 
Despite extensive attempts to measure coping strategy they, certainly do not exhaust all 
the possible ways an individual can react in a situation (Singer, 1984). Consequently, 
there is no guarantee that an experimentally suggested coping mechanism will be the 
optimal strategy for a particular situation. Research in relation to coping with chronic 
illness in general, and more specifically with psoriasis and eczema, is discussed below. 
1.5.3 Coping with Chronic Mness 
Shannon (1996) defines chronic illness as a condition that continues for six months or 
more and requires ongoing medical management. In contrast to acute illness, in chronic 
illness the likelihood of cure is low and symptom management rather than cure is the 
medical goal. Individual differences in reaction to chronic illness exist, with some 
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adults being more distressed than others. A critical assumption of current conceptions of 
coping is that coping strategies may have different consequences when used in response 
to different types of stress. Thus, the effectiveness of any given strategy depends upon 
its appropriateness for the particular stress faced (Felton, Revenson and Hinrichsen, 
1984). In a review of studies of coping and chronic illness, Felton el al. (1984) found 
results to be mostly anecdotal or single case studies of specific illness. Depending on 
the definition of coping and the nature of the illness studied, typical coping strategies 
identified included denial, selective ignoring, information seeking, reminiscence about 
former good times, learning specific illness -related procedures, blaming others or 
seeking comfort from others. To eliminate the focus on a specific illness, the Felton et 
al. (1984) study focuses on comparison of the coping paradigm in four different 
illnesses. They concluded that there are no significant differences in coping strategies 
used by individuals with different illnesses. However, a significant relationship was 
found between measures of adjustment and coping strategies of wish fulfilling fantasy, 
emotional expression and self blame, which suggest that individual coping effects are 
not altogether positive. Using such strategies did not appear to promote acceptance of 
illness nor protect the individual from feeling depressed and consequently the authors 
suggest that overall emotion -based coping is related to poorer adjustment. This view is 
supported by Maes, Leventhal and DeRidder, (1996), who suggest that a coping style 
which is characterised by being active, expressive and thinking positively results in 
significantly higher levels of physical and psychological functioning. More positive 
scores on clinical measures of disease and higher levels of psychological well being 
usually reflect this. This is a particularly important point as long term physical health 
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can be a consequence of emotional state and, if coping strategies are ineffective, further 
deterioration of physical health may be the outcome. Consequently, a vicious cycle of 
illness -based stress, ineffective coping and poor emotional adjustment may develop. 
1.5.4. Coping with Eczema and Psoriasis 
Few studies have been conducted in the area of coping with stresses associated with 
having psoriasis (Wahl, 1997) and to date there does not appear to have been any 
research examining coping in individuals with eczema. 
Studies examining specific coping strategies are limited. In one of the earlier studies, 
Coen (1976) examined ways in which individuals with psoriasis dealt with their skin 
condition. She identified that individuals with psoriasis tend to use behavioural 
strategies, such as concealment and avoidance of the unpleasant reactions of others, 
above other psychological defence mechanisms. Coen (1976) also identifies other 
frequently used coping behaviours such as drinking alcohol, joking about their condition 
and comparing it with other diseases that they perceived to be worse. In a more 
systematic exploration of coping in psoriasis sufferers, Taylor and Buckwalter (1988) 
examined the frequency of emotion focused strategies and problem solving approaches 
used, and the relationship between biographical data and the use of particular coping 
devices. Seventy subjects participated in the study, which used the Jalowiec Coping 
Scale (Jalowiec and Pares, 1981). This coping measure classifies 40 specific coping 
strategies as either problem- orientated or emotion -orientated. Results suggest that 
individuals with psoriasis use a variety of coping strategies and that each of the 40 
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strategies was used by at least one of the participants. The most frequently used 
methods in this study were control, objectivity, finding different solutions to the problem 
and information seeking to enhance the process of acceptance and problem solving. 
Using open -ended questions about actual strategies used, the authors identified coping 
strategies not mentioned in the questionnaire. These included concealment, education of 
others about the disease, and seeking of appropriate and effective treatment for their skin 
condition. In comparing demographic data with coping scores, differences were noted 
on two variables. Younger individuals, 18 -40 years, were more likely to use both 
problem and emotion orientated strategies than older age groups. Significantly more 
emotion -focused mechanisms were used by the females in the study. Further research is 
required to support these findings, especially as there has been no attempt to categorise 
methods used, other than in broad terms of being problem or emotion -focused strategies. 
Frequently, the assumption is made that poorer outcome is experienced when emotion 
focused strategies are used, but further research is required to confirm this in individuals 
with psoriasis. 
Other studies have attempted to compare coping mechanisms used across varying 
chronic medical conditions. Scharloo, Kaptein, Weinman, Hazes, Willems, Bergman 
and Rooijmans (1998) examine coping styles and illness perception to explain 
functioning in individuals with psoriasis, rheumatoid arthritis and obstructive pulmonary 
disease. Coping was measured using a Dutch coping inventory (Schreurs, P., Tellegen, 
B. and Van de Willige, G., (1984). The seven sub -scales of this measure explore 
seeking distraction, expressing emotions, fostering reassuring thoughts, passive coping 
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and active coping. Results confirmed previous research indicating that passive coping is 
associated with poorer outcome while seeking social support and belief in controllability 
reflected a better outcome. The results also suggested that illness representations have a 
significant and direct effect on functioning while this is not mediated by coping 
strategies used. The authors reported that, in relation to illness perception, the patients 
who believed that their psoriasis was likely to last a long time and have serious 
consequences were found to be functioning less well. Scharloo et al. (1998) suggest that 
interventions aimed as increasing an individual's personal control, and changing beliefs 
about the course of the illness, could be associated with general changes in overall 
psychosocial functioning. 
1.5.6 Summary 
The concept of coping is complex and difficult to define. Research examining coping in 
relation to chronic illness generally, concludes that coping style can influence the 
outcome of an individual's illness. Research into coping in skin diseases is clearly 
lacking. One area where there has been an expansion in research in dermatology is in 
relation to quality of life as discussed below. It has been suggested that quality of life is 
linked with both experience of stigma and coping mechanisms. 
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1.6 QUALITY OF LIFE IN DERMATOLOGY 
1.6.1 Background 
In the past twenty -plus years, there has been a wealth of research examining quality of 
life issues. A review of this general literature would be impossible within the context of 
this study. Both general and specific quality of life measures focus on the impact of 
disability and handicap caused by specific impairment. Finlay and Ryan (1996) define 
these three features in reference to dermatological conditions. Impairment refers to the 
effect of the disease process on a diseased organ, such as the persisting fissures and 
scaling of the skin found in psoriasis and eczema. Disability describes the functional 
effects of this impairment, such as an inability to use a keyboard due to pain or altered 
sensations in the hand with dermatitis. Handicap therefore describes the effect on the 
patient's normal functioning as a consequence of the disability. In the example of the 
keyboard operator, this may involve no longer being able to continue to work. The 
authors indicate that these terms often become confused within the literature. Although 
general health measures have proved useful in research, dermatology -specific measures 
are required for day to day clinical use (Finlay and Ryan, 1996). Methods of measuring 
disability caused by skin disease are required for a variety of reasons. These include the 
need to assess the effectiveness of new therapies, to allow comparisons between skin 
diseases, and audit the effectiveness of clinical outcomes (Finlay and Khan, 1994). 
Quality of Life measures could also be viewed as an effective means of identifying 
individuals with marked disability, who may benefit from psychological approaches. 
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The following review will concentrate on the concept of quality of life within 
dermatology. Despite the obvious impact having a chronic skin condition has on an 
individual's quality of life, research in dermatology has lagged behind similar research 
in other medical conditions (Finlay and Coles, 1995; Morgan, McCreedy, Simpson and 
Hay, 1997). 
1.6.2 Disease Specific Quality of Life Measures 
In reference to the conditions examined in the current study the Psoriasis Disability 
Index (Finlay and Khan, 1994) was one of the first disease specific measures to examine 
quality of life issues. The Psoriasis Disability Index (PDI) is a 15 item measure relating 
to psoriasis related problems experienced in the past four weeks. Items specifically 
address self -reported disability in areas of daily activities, employment, personal 
relationships, leisure and treatments effects. The measure was validated against general 
health questionnaires such as the UK Sickness Impact Profile (Finlay and Kelly, 1987; 
Finlay, Khan, Luscombe and Salek, 1990). 
Finlay and Coles (1995) undertook an extensive study using the Psoriasis Disability 
Index to quantify levels of disability experienced by patients with psoriasis and the value 
individuals placed on their disease. This was a UK wide survey with dermatologists 
asking patients to complete the PDI, rate psoriasis against a comparable disease and to 
indicate the importance placed on their skin disease (time prepared to treat, cost). 
Results indicated that psoriasis has a significant effect on perceived quality of life. Of 
those patients who were currently employed (59.3 per cent), a mean number of 26 days 
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per year were lost due to problems with their psoriasis. Of those participants who 
indicated they were retired, 33.9 per cent attributed their retiral to their psoriasis. In 
patients who also suffered from one of the comparable diseases (diabetes, asthma or 
bronchitis), the predominant response was that having psoriasis was worse than having 
the other illness. Interestingly, the majority of those without a comparative disease 
thought it would be worse to have a disease other than psoriasis. This perhaps reflects 
the view that patients with psoriasis frequently minimise the extent of their illness (Metz 
and Jemes, 1996). In relation to the value placed on the skin condition, 49 per cent of 
the patients indicated that they would be prepared to spend two to three hours each day 
on treatment, if this would result in normal skin for the rest of the day. Nearly all the 
patient in the survey indicated that they would prefer a cure rather than a gift of one 
thousand pounds. However, if they had perhaps known the true costs of treating 
psoriasis a different picture may have emerged. Cork (1993) calculated that the overall 
cost of drug therapy for severe psoriasis was over £800 per annum, PUVA therapy was 
over £500 per treatment course, and a single two week admission to hospital costs nearly 
£3,000 for the bed alone. Costs of eczema patients are likely to be very similar. 
The Psoriasis Disability Index has also been used to compare the impact of clinical 
severity, anatomical location and treatment in psoriasis (Fortune, Main, O' Sullivan and 
Griffiths, 1997b). This study also examined psoriasis related stress on patients' physical 
and mental health and on areas of disability in everyday life. Results indicated that 
severity of psoriasis, duration of skin condition, gender and anatomical locations were 
unrelated to impairment in any specific area of quality of life. However, it was reported 
37 
INTRODUCTION 
that stress from anticipating the reaction of other people to their psoriasis, contributed 
more to the variance of patients' disability in everyday life than any other variable. 
Such evidence links to the research exploring stigmatisation in skin conditions and 
provided evidence that actual or perceived stigma can be one of the most debilitating 
factors in having a skin disease. 
1.6.3 General Dermatology Quality of Life Measures 
In order to assess quality of life across a number of dermatological conditions, Finlay 
and Khan (1994) developed the Dermatology Life Quality Index (DLQI). This was 
based on previous research, mainly the Psoriasis Disability Index (Finlay and Kelly, 
1987; Finlay et aL, 1990) and the Acne Disability Index (Motley and Finlay, 1992). In 
the development of the DLQI, 120 patients with different skin diseases were asked about 
the impact of their disease and its treatment on their lives. The DLQI was developed 
based on the answers received and then tested on 200 consecutive outpatients. It was 
hoped that the measure would provide a compact assessment (10 items) applicable to 
routine clinical practise. As expected the DLQI, confirmed that atopic eczema, psoriasis 
and generalised pruritus have greater impact on quality of life than other skin conditions 
such as warts or skin cancers. 
A few studies have since been undertaken using this measure, including a study 
focussing on quality of life in atopic dermatitis (Finlay, 1996; Linnet and Jemec, 1999). 
The DLQI has also been used to measure effectiveness of inpatient treatment (Kurwa 
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and Finlay, 1995) and has been adapted for use with children (Lewis -Jones and Finlay, 
1995). 
In the Linnet and Jemec study (1999), the DLQI was used in an investigation of the 
relationship between the severity of atopic dermatitis, anxiety and life quality. As 
reported earlier, atopic dermatitis patients had significantly lower dermatological life 
quality than a control group. Interestingly, this study found some seasonal differences in 
responding on the DLQI, which suggests that life quality can fluctuate in varying 
circumstances and with improvements in the skin condition. In this study the numbers 
are perhaps too small to draw any firm conclusions, but it suggests that results should be 
treated with caution if subjects are tested at different times of the year and at differing 
stages in treatment. Although severity of eczema and trait anxiety were significantly 
related to items on the DLQI; in this study they were not related to each other. Severity 
of the eczema related more to items of practical care and management, whereas Trait 
Anxiety showed a more significant relationship to items regarding intimacy and body 
exposure. However, given the limited number of questions relating to these items, 
further research would be required to confirm this finding. 
With the exception of Finlay and Khan's (1994) questionnaire, measures relating to 
quality of life in dermatology have largely been disease specific (Finlay & Coles, 1995; 
Fortune, Main, O'Sullivan and Griffiths, 1997a; Motley & Finlay, 1992). The majority 
of these questionnaires are limited in examining the psychosocial impact of having a 
chronic skin condition. To redress this, Morgan et al. (1997) developed the 
Dermatology Quality of Life Scales (DQLS) with a greater emphasis on the 
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psychosocial domain. The measure was developed by asking 50 individuals to rate the 
ways in which their skin condition affected them in terms of feelings, personal 
relationships, daily and social activities. From this, a scale of 17 psychosocial and 12 
activity items were identified. Testing, on individuals aged 13 to 84 years of age on a 
variety of skin conditions, including psoriasis, eczema and acne, revealed high internal 
consistency and construct validity. The authors concluded that the result were 
comparable to many other disease -specific measures. As predicted, psychosocial scores 
were higher for eczema and psoriasis than in other conditions, such as skin cancer. 
Younger individuals tended to have higher psychosocial scores. Results also confirmed 
the findings of other studies, which suggest that the psychosocial impact is greater for 
women than men. This measure consequently overcomes the recognised problem of 
generic health status measures to the effects of specific diseases. This measure was used 
in the current study. 
1.6.4. Qualitative Approach to Measuring Quality of Life 
Studies that qualitatively explore the handicap that results from skin disease are rare. 
Jowett and Ryan (1995) used an interview method to explore occupational, social and 
emotional functioning in patients with eczema, psoriasis and acne. Interviewees were 
asked detailed questions about the history extent, and severity of their condition, their 
employment experiences (including any difficulties caused by their skin disease), any 
limitations on their leisure activities, and their subjective responses to the disease. The 
results focus on the negative impact skin disease has on the interviewees' lives. 
Negative experiences were reported across all the areas studied. This study could be 
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criticised for a failure to emphasise any positive coping styles adopted to cope with 
difficulties faced. With such detailed information, the authors should have been able to 
explore differences across the three conditions rather than analysing them together. The 
authors concluded that it is important to improve the psychological and social 
environment of those with skin disease, by educating the general public and developing 
techniques to help the patient cope effectively with difficulties faced. 
1.6.5 Summary 
It is clear that the concept of quality of life is especially relevant in the study of skin 
disease. It seems that one group of researchers have conducted much of the work in this 
area. Further research is required to refine existing measures with more attention to 
psychosocial factors and perhaps links to common themes explored in the literature on 
stigmatisation. There appears to be scope for the use of quality of life measures in 
evaluating psychological methods of treatment. As much of the research highlights the 
need for psychological approaches, existing approaches are described below. 
1.7 PSYCHOLOGICAL INTERVENTION IN DERMATOLOGICAL 
CONDITIONS 
1.7.1. Background 
Given the recent increases in the research examining quality of life and stigmatisation 
issues in dermatology it would be expected that psychological approaches would have 
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emerged to deal with difficulties identified. Although treatments have been reported, the 
majority involve small numbers with little consistency to allow comparison between 
treatments. It has been recognised that psychological factors influence the outbreak and 
exacerbation of many skin conditions but, despite this, dermatology as a profession has 
not always recognised the need for psychological interventions (Beaman and Luzzato, 
1988). Some authors have suggested that the incorporation of psychological models into 
dermatology is of far greater importance than other specialities such as cardiology, and 
cosmetic surgery, where extensive research has been carried out (Van Moffaert, 1982). 
This does not only apply to medical settings. Others have suggested that psychological 
approaches are just as important in managing dermatological conditions in a primary 
care setting (Mackie, 1991). This is particularly relevant considering the small numbers 
of individuals with skin conditions that seek referral to dermatologists and the large 
numbers seeking help from their general practitioner or coping alone. 
Below, some of the varied psychological treatment studies in eczema and psoriasis are 
discussed. Although many of the psychological therapies overlap, and in some cases are 
identical, there are no studies that compare or contrast the psychological treatment of the 
two conditions together. In a general review of psychological approaches, the main 
treatment options identified were relaxation training, biofeedback, hypnosis, operant 
conditioning and cognitive- behavioural therapy (Tsushima, 1988). Given the lack of 
well -controlled and replicated studies to date, it is crucial that current levels of 
knowledge in relation to these treatments in dermatology are viewed as tentative. 
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1.7.2 Psychological Approaches to Psoriasis 
The literature pertaining to psychological treatment approaches in psoriasis is often very 
varied and at times vague. Much of the research has focused on means of reducing the 
symptoms or dealing with the stress thought to exacerbate the condition. 
In a small study exploring the use of hypnosis, subjects were assigned to a hypnosis only 
group, hypnosis plus PUVA treatment or PUVA treatment alone (Boncz, Farkas and 
Hunyadi, 1990). Positive results were reported, with hypnosis being implicated in the 
termination of unpleasant symptoms such as itching, tenseness of the skin and sleeping 
difficulties. In terms of improvement in skin condition, the group, which had PUVA and 
hypnosis, fared best. In a study with only 27 participants, it is again difficult to draw 
any firm conclusions. It would be interesting to know if there were any variations in 
responses to hypnotic susceptibility and suggestion across the variety of measures. 
In a larger scale study, (Zachariae, Oster, Bjerring and Kragballe, 1996), 51 patients 
were randomly assigned to a treatment or to a control group. Treatment lasted twelve 
weeks and included group work plus individual psychotherapy sessions. Interventions 
included stress management, guided imagery and relaxation. All outcome measures 
were based on dermatological indices, skin severity and immunological mechanisms. 
Results showed a slight but significant improvement on all dermatological measures for 
the treatment group in comparison with the control group. Although the authors 
concluded that the intervention had a moderately beneficial effect on psoriasis activity, 
longer follow -up may have yielded results that were more positive. This study could 
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have also benefited from the inclusion of psychological measures, as other studies have 
suggested that a reduction in psychological distress does not necessarily correspond with 
improvements in skin condition. 
Another study using a randomised time -series study, explored four approaches to the 
psychological treatment of psoriasis (Gaston, Crombez, Lassande, Bernier -Buzzanga 
and Hodgins, 1991). The two experimental groups were individuals receiving 
meditation, or meditation and imagery. The control groups were either placed on a 
waiting list or receiving no treatment. Treatment lasted twelve weeks. Numbers in each 
of the groups were very small, four or five. Four subjects showed improvement in their 
psoriasis as rated by a dermatologist, the rest did not deteriorate. The authors suggest 
reduction in symptom severity could be explained by individuals following explicit 
instructions to reduce symptoms or merely by the belief that they were being helped by 
the treatment. Clearly, a replication of this study using a far larger number of subjects is 
required to clarify this issue. 
1.7.3 Psychological Approaches to Eczema 
James (1995) suggests that there are a number of psychological approaches that can be 
offered to improve the quality of life in eczema sufferers. These include reducing itch 
levels by lowering sympathetic activity, use of behavioural methods to modulate 
scratching behaviour, stress management and counselling to help families and 
individuals cope. Obviously, the selection of suitable patients for such approaches is 
crucial, requiring development and utilisation of various screening tools. It has been 
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suggested that three types of patients with eczema and psoriasis can be identified. The 
first is those who are best helped by social interventions (e.g. education), a second group 
who benefit from stress management and a third group who require deeper attention to 
personal problems through psychotherapy (Beaman and Luzzato, 1988). To date, the 
therapeutic benefits of psychological interventions, beyond those of standard medical 
treatments, has received little attention in dermatitis (Ehlers, Stangier and Gieler, 1995). 
Much of the research in eczema has focused on behavioural approaches particularly in 
the management of the itch -scratch cycle. More recently, there have been attempts to 
introduce cognitive- behavioural approaches to tackle the range of problems associated 
with having eczema. De L. Home, White and Varigos (1980) present three case studies 
using a cognitive -behavioural approach to the management of eczema. The approach 
involved some general elements that included self -monitoring of eczema severity, 
identification and recording of cognitive and environment triggers to flare -ups, and 
relaxation training using imagery, and habit reversal. All three cases showed a post 
treatment reduction in symptom severity, increase in ability to control symptoms such as 
scratching, and a decrease in reliance on medication. As a small pilot study, it is 
difficult to make any firm conclusions about the effectiveness of the approach, 
especially given two patients received less than 10 sessions while the third received 33. 
The authors suggest a controlled treatment trial would be required to evaluate the 
different treatment components used in this study. In order to assess the value of 
psychological approaches in relation to standard medical treatments of skin conditions, 
Ehlers et al. (1995) developed a randomised control trial, exploring four psychological 
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treatments. The treatment groups consisted of a dermatological education programme, 
autogenic training as a form of relaxation, cognitive -behavioural therapy and combined 
education and cognitive -behavioural therapy. Results indicated that psychological 
treatments led to a significant and stable addition to treatment. At one year follow -up, all 
interventions with the exception of education alone, showed significantly larger 
improvements in skin condition than standard medical treatments alone. Improvements 
were accompanied by a reduction in the use of topical steroids. In addition, although 
none of these treatments targeted anxiety or depression directly, measures in these areas 
were decreased in all four groups post treatment. 
1.7.4 Summary 
The scope for psychological intervention is great but, to date, evaluation and 
development of techniques has been limited. Results look promising for cognitive - 
behavioural approaches in dermatology but more extensive research is required. As it 
has been suggested that coping style influences outcome in chronic illness, further work 
is perhaps required to provide interventions for improving coping mechanisms in skin 
conditions. Intervention is beyond the scope of this study but is discussed within the 
context of future studies. 
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1.8 PRESENT STUDY: AIMS AND HYPOTHESES 
1.8.1 Aims 
The study aims to examine the impact of having a skin disease on life quality and 
experience of stigma through replication of the findings of previous studies. In addition, 
a novel aspect of this present study was to examine coping style in relation to 
stigmatisation and quality of life, and to compare differences between individuals with 
eczema and psoriasis. Therefore, the hypotheses are divided into two sections exploring 
current research findings and the experimental hypotheses for this study. 
1.8.2. Hypotheses 
From the Research Literature 
1. a. Females will report reduced quality of life in comparison to males. 
1. b. Females will report greater stigma experience than males. 
2. a. Younger age at onset and younger current age will have a negative impact on 
stigma experience. 
2. b. Younger age at onset of skin disease and younger current age will affect of 
quality of life reported. 
3. a. Greater visibility of skin disease will lead to greater impairment in quality of life. 
3. b. Greater visibility of skin disease will lead to greater experience of stigma. 
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4. Levels of psychosocial distress will be lower in individuals who adopt active 
problem solving approaches to coping. 
Levels of psychosocial distress will be higher in individuals reporting greater stigma 
experience. 
Experimental Hypothesis 
6. a. Individuals with psoriasis and eczema will report similar experiences of having a 
skin complaint (stigmatisation). 
6. b. Quality of life will be similar for individuals with eczema and psoriasis. 
7. Individuals who report high levels of stigmatisation will report similar coping styles. 
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A between -groups design was used with measures of stigma experience (Experience 
of Skin Complaints), coping style (the COPE scale) and psychosocial problems 
(Dermatology Quality of Life Scales). Participants were placed in two groups 
according to their skin condition, either eczema or psoriasis. At the initial stages of 
this study it was hoped to have four groups to allow comparison between both 
inpatients and out patients with eczema and psoriasis. Due to time constraints, and 
smaller numbers of patients with eczema, than expected this was not possible. 
Previous research studies examining psychological factors in dermatology have 
tended not to distinguish between inpatients and outpatients or between skin 
conditions. Each participant was seen on at least one occasion. A sample of 
individuals volunteered to attend for an interview with the researcher, following 
completion of the questionnaire methods. 
The Tayside Committee on Medical Research Ethics granted approval for this study 
to be carried out. Minor changes were requested for the patients' information leaflet, 
but no changes were made to the research design. 
2.2 PARTICIPANTS 
The participants were all current patients of the Dermatology Department at a large 
teaching hospital. Initially, 102 patients were approached and asked if they were 
willing to participate in the study. Thirty -one participants failed to return the 
questionnaire measures. Of the 71 questionnaires returned, seven were excluded as 
they did not fulfil the criteria, or the participant had failed to complete one of the 
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measures. This left 64 participants in the study. Thirty males and thirty -four females 
participated in the study. The majority of patients (n =59) were approached by the 
researcher to participate in the current study. The dermatology treatment nurse and 
the senior charge nurse in the photobiology unit approached the other five patients. 
Participants were placed in one of two groups according to their skin condition, 
psoriasis or eczema. The psoriasis group (n =39) included both inpatients (n =10) and 
outpatients (n =29). The second group consisted of patients with a primary diagnosis 
of eczema (n =25) which also consisted of inpatients (n =6) and outpatients (n =19). 
Participants in both the eczema and psoriasis groups were currently receiving 
treatment by physicians for their skin condition. 
Criteria for inclusion in the study were: 
Adolescents and adults currently patients of the Dermatology Department' 
Skin condition present for more than six months. 
The main exclusion criteria was: 
An individual in current treatment in the Clinical Psychology Department 
The youngest participant was 15 and included due to sample size consideration after full parental 




2.3.1 Experience of Skin Complaints (EoSC) 
This is a 34 -item scale developed by Schmid -Ott et al. (1996) to identify dimensions 
of stigma experience in patients with chronic skin disease. This scale expands a 
previous questionnaire designed by Ginsburg and Link (1989), that examines stigma 
experience in individuals with psoriasis. Five factors are identified in relation to 
stigma experience. 
1) Self -esteem: This relates to interference of skin symptoms and self -esteem and 
includes feeling worthless, alone or unclean as a consequence of having a skin 
disease. 
2) Retreat: This factor corresponds to outer appearance and situation -caused 
retreat. This describes feeling physically or sexually unattractive and 
avoidance of social situations when skin condition is bad. 
3) Rejection: Rejection and devaluation items comprising of anticipated or 
experienced negative reactions from others. 
4) Composure: This scale describes calmness and confidence in quality of life in 
spite of having a skin condition. 
5) Concealment: The final scale comprises tendencies for hiding the diagnosis 
and keeping the skin condition a secret. 
Scores can be obtained for each factor as well as a total experience of skin complaint 
score. Higher scores indicate a greater degree of feelings of stigmatisation. In the 
original study, items were scored on a six point scale from strongly agree to strongly 
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disagree. It was thought that a neutral midpoint would be more desirable and would 
not increase disagreement with the original study. Consequently, in this study 
responses are measured on a five point scale from strongly agree to strongly 
disagree, including a neutral midpoint (Appendix 1). For the original study, 
construct validity on the EoSC was assessed comparing interrelations with skin 
symptomatology, regions affected and social characteristics for 187 patients with 
eczema, psoriasis and acne. The internal consistency for each factor was calculated 
using Cronbach's Alpha (self -esteem = 0.87, retreat = 0.86, rejection = 0.87, 
composure = 0.76 and concealment = 0.76). The questionnaire was found to be a 
reliable and valid measure. Permission was obtained from the authors to use the 
EoSC in the current study. 
2.3.2 COPE 
Designed by Carver, Scheier and Weintraub (1989) the COPE is a comprehensive 
measure of coping and can be used to examine both situational (responses to a 
specific situation or period of time) and dispositional (typical responses to stressors) 
coping. In the current study situational coping was examined. The COPE was given 
with the instruction; 
`We are interested in how people respond when they confront difficulties in 
their lives, such as having a chronic skin condition. This questionnaire asks 
you to indicate what you generally do and feel about having a skin condition'. 
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The COPE is a 52 -item measure consisting of 13 distinct scales. These are outlined 
below. 
1) Active Coping: taking action, and exerting efforts, to remove or circumvent 
the stressor. 
2) Planning: thinking about how to confront the stressor, planning one's active 
coping efforts. 
3) Seeking Instrumental Support: seeking assistance, information, or advice 
about what to do. 
4) Seeking Emotional Social Support: getting sympathy or emotional support 
from someone. 
5) Suppression of Competing Activities: suppressing one's attention to other 
activities in which one might engage, in order to concentrate more completely 
on dealing with the stressor. 
6) Turning to Religion: increased engagement in religious activities. 
7) Positive Reinterpretation and Growth: making the best of the situation by 
growing from it, or viewing it in a more favourable light. 
8) Restraint Coping: passively coping by holding back one's coping attempts 
until they can be of use. 
9) Acceptance: accepting the fact that the stressful event has occurred and is 
real. 
10) Focus on and Venting of Emotions: an increased awareness of one's emotion 
distress and a tendency to discharge those feelings. 
11) Denial: an attempt to reject the reality of the stressful event. 
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12) Mental Disengagement: psychological disengagement from the goal with 
which the stressor is interfering, through daydreaming, sleep or self -distraction. 
13) Behavioural Disengagement: giving up, or withdrawing effort from, the 
attempt to attain the goal with which the stressor is interfering. 
Since Carver et al. (1989) developed the COPE, two additional scales have been 
added, alcohol/drug use and humour. These are regarded as still being in exploratory 
stages and limited data is currently available on the validity of these scales although 
internal consistency is noted to be high (Weinman et al., 1995). 
There are separate scores for each of the 15 scales and these are calculated by adding 
the scores on four items that make up each scale. Scores range from 4 to 16 for each 
of the scales. The revised version of the COPE has 60 items in total (Appendix 2). 
2.3.3. Dermatology Quality of Life Scales (DQLS) 
The Dermatology Quality of Life Scales were developed by Morgan et al., (1997) to 
assess the impact of skin conditions on the patient's psychosocial state and everyday 
activities. The scales were designed as a comprehensive measure of the impact of 
skin conditions on health related quality of life. The authors suggest that this 
measure is much more sensitive to the impact of skin problems than a generic health 
status measure, especially in the psychosocial sphere. The measure contains 29 
items (17 psychosocial and 12 activities). Psychosocial items relate to 
embarrassment, despair, irritability and distress (anxiety and depression). Items on 
the activity scale relate to everyday tasks, summer, social and sexual activities. Each 
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item is rated on a five point scale: very slightly or not at all (0) to extremely (4). 
Scores are adjusted to be within the range of zero to 100. Higher scores indicate a 
greater impact on quality of life. The questionnaire was tested on 118 outpatients of 
a dermatology department and internal consistency was shown to be high 
(Cronbach's Alpha 0.92 for psychosocial items and 0.83 for activity items). 
Reliability was tested on 41 outpatients and showed good short-term test retest 
reliability. Construct validity was confirmed by the ability of the scale to identity 
clinically expected differences. Permission was obtained from the authors to use this 
questionnaire in the current study (Appendix 3). 
2.3.4. Background Information 
General information was collected via the patient information sheet (Appendix 4). 
This included: 
Type of skin condition 
Age 
Length of time with condition 
Age at onset of skin condition 
Anatomical location of skin condition 
It is well known that the objective measurement of skin condition severity is 
problematic, due to participants being recruited at different points in treatment and 
both psoriasis and eczema severity being subject to seasonal variation. 
Consequently, actual severity was not assessed in this study. Gupta et al (1998) 
suggest that the location of the skin condition may be a more valid measure. They 
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suggested that skin conditions which predominate in socially visual areas such as the 
face and hands should be classed as `emotionally charged' regions in comparison to 
other parts of the body. As a crude measure, participants whose skin condition 
predominated on the face, head, hands and wrists were classed as `emotionally 
charged' and those whose condition was mainly located on the arms, torso and legs 
were classed as `not emotionally charged'. In addition a third category was included 
in this study for participants with both emotionally and non -emotionally charged 
areas of skin disease. 
2.3.5 Semi -Structured Interview 
The first fifty participants in the study were asked if they wished to participate 
further in the study by attending for a short interview. Of those who responded, 
(n =20) ten attended interviews either at the Clinical Psychology Department or were 
seen by the researcher in their own homes. The interviews all followed a similar 
outline, exploring problems associated with having a skin disease, personal 
experience of being stigmatised and general ways of coping (Appendix 5). 
Participants were asked specific questions in relation to the above issues, but were 
free to discuss personal experiences relating to their own skin conditions and any 
issues raised from completion of the questionnaire methods. The intention of 
conducting the interviews was to provide qualitative information to augment results 




Participants in the study were identified according to treatment location. The main 
settings were the dermatology ward, photobiology unit and the dermatology 
outpatient department, attached to a large teaching hospital. Suitable participants 
were identified by dermatology staff and then approached by the researcher and 
asked if they wished to participate in the study. As noted earlier, a small number of 
participants (n =5) were approached by the dermatology treatment nurse and senior 
charge nurse, and were not seen by the researcher. Participants were given an 
information sheet to read, explaining the nature of the study and encouraged to 
contact the researcher should they have further questions (Appendix 6). Due to the 
time constraints of dermatology appointments, participants were encouraged to 
complete the measures in their own time and return these via a self -addressed 
envelope. Participants, who were patients on the ward, returned the completed 
measures to ward staff in a sealed envelope. The consultant dermatologists were 
informed as to which of their patients had participated in the study. As not all 
participants in the study knew the name of their consultant, a complete list of 
subjects was retained by the researcher in case further information was required. As 
mentioned above, the first fifty participants were invited to participate further in the 
study by attending for a short interview (Appendix 7). These interviews took place 
in the participant's own homes, dermatology ward or at the clinical psychology 
department of the same hospital where they receive treatment. Appointments were 
arranged, whenever possible, within three weeks of completion of the questionnaire 
measures. An opportunity to discuss issues raised by the questionnaires was offered 
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during the interviews. Interviews, which were tape- recorded and fully transcribed, 
lasted between 20 and 50 minutes and were conducted by the researcher. 
2.5 ANALYSIS OF DATA 
2.5.1 Data Analysis 
All statistical analyses were carried out using the Statistical package for Social 
Sciences (SPSS) for Windows 95, Version 9. Relationships between variables were 
calculated using between group t- tests, correlations and multiple regression. 
In analysing the qualitative data, repeated readings of the transcripts suggested a 
number of ways that participants think about their skin conditions. These formed the 
themes around which the analysis was organised. Current literature, examining 
coping and stigmatisation issues, was also consulted to facilitate development of 
themes for analysis. Transcripts were coded for each of the identified themes. 
2.5.2 Statistical Power 
Following discussion with one of the Consultant Dermatologists and Charge Nurse in 
the Dermatology department, where the study took place, it was expected that at least 
100 patients could be identified over the four -month period of the study. Allowing 
for the potential of the low response rate typically associated with questionnaire 
designs, the sample size was expected to be at least 30 in each group. Consequently, 
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a large effect size was anticipated. This satisfies with Cohen's (1992) criteria on 
statistical power. 
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CHAPTER 3 - RESULTS 
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3.1 DEMOGRAPHIC DATA 
3.1.1 Exploration of data 
Prior to statistical analysis, the data was explored. Where applicable, the data was 
explored for skewness and kurtosis. Significant results are reported at the <0.05 
level and all significant results are reported in bold type. 
3.1.2 Participants 
One hundred and two individuals were approached and agreed to participate in this 
study. Two individuals refused. Respondents were asked to complete the 
questionnaires in their own time and return them at their next appointment, or 
directly to the researcher via a stamped addressed envelope. Inpatients returned 
questionnaires to nursing staff to be passed to the researcher. Seventy -one 
questionnaires were returned equating to a response rate of 70.3 percent. Seven of 
these respondents were excluded from the study, as they did not fulfil the criteria, 
mainly they had had their skin condition for less then six months, or did not complete 
all the questionnaire measures. In all sixty -four participants were included in the 
study. 
Subjects were separated into two groups, based on their skin condition. In all, 39 
participants were included in the psoriasis group and 25 participants included in the 
eczema group. Table I shows the frequency of male and female participants and 
where participants were receiving treatment for their skin conditions. 
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Table 1: Age and Location of Treatment 
Skin Condition Gender Treatment Location 
Male Female Outpatient Inpatient 
PSORIASIS 17 22 29 10 
ECZEMA 13 12 19 6 
Total 30 34 48 16 
In the initial stages of the study, it was planned to separate the psoriasis and eczema 
groups further by differentiating between participants who were inpatients or 
outpatients at time of recruitment into the study. Due to the small number of suitable 
inpatients, this division was not completed. 
3.1.3 Age 
Both psoriasis and eczema can effect adults at any age. Figure 1 and Table 2 
examine the mean age and distribution for each group in this study. 
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Figure 1: Histogram for Age in Psoriasis and Eczema Groups 
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Table 2: Mean Age in Psoriasis and Eczema Groups. 
Skin 
Condition 
N Mean Minimum Maximum Std. 
Deviation 
PSORIASIS 39 47.69 20 79 16.12 
ECZEMA 25 34.44 15 74 16.73 
Total 64 42.52 15 79 17.48 
Figure 1 and Table 2 suggest that there may be some discrepancy between 
distributions for both groups. A between groups t -test was conducted to compare 
ages in both groups (t = 3.16, df = 62, p < .01, one -tailed). 
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It was expected that there would be differences in the mean age of onset between the 
two conditions, as eczema generally develops in childhood while psoriasis generally 
develops in adulthood. Figure 2 and Table 3 report the mean age of onset of skin 
condition for both groups. 
ó u 
Figure 2: Histograms for Age at Onset in Psoriasis and Eczema Groups 
skincond = 1 skincond = 2 
ageonset ageonset 
skin condition 1 = Psoriasis skin condition 2 = Eczema 




N Mean Minimum Maximum Std. 
Deviation 
PSORIASIS 35 28.12 8 77 17.42 
ECZEMA 25 14.16 0 73 21.46 
Total 60* 22.30 0 77 20.26 
*Information on age at onset of skin condition was missing for our participants. 
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To establish if the differences between the two groups are significant a between - 
samples t -test was completed (t = 2.78, df = 58, p < .01, one -tailed). 
Length of time an individual has had a skin condition may be an important 
consideration when analysing the effect of other variables. Figure 3 and Table 4 




Figure 3: Histogram for Time with Skin Condition for Psoriasis and 
Eczema Patients 
skincond = 1 skincond = 2 
timewith timewith 
skin condition 1 = Psoriasis skin condition 2 = Eczema 
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N Mean Minimum Maximum Std. 
Deviation 
PSORIASIS 35 20.26 1 66 15.62 
ECZEMA 25 20.30 0.5 50 13.60 
Total 60* 20.28 0.5 66 14.69 
*Information on length of time with skin condition was missing for four participants. 
To establish if the differences between the two groups are significant, a between- 
samples t -test was completed (t = .011, df = 58 p = NS, one -tailed). 
3.1.4 Location of Skin Disease 
Objective measurement of skin severity is recognised as being difficult to obtain. 
Consequently, the location of skin disease was used as a distinguishing measure. As 
discussed earlier, this is based on the Gupta et al. (1988) distinction between 
emotionally charged areas (face, hands, wrists and genital region) and non - 
emotionally charged areas (legs and torso). Following consultation with 
dermatology staff, a category for skin lesions in the genital region was not included 
as it was suggested this may have a negative impact on participation in the current 
study. An additional category of `all over' was included in this study to include 
participants with lesions in both emotionally and non -emotionally charged areas. 
Graph 4 and Table 5 show the frequency of participants with psoriasis and eczema in 
each of the three categories. 
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Figure 4: Bar Graph to Show Frequency of Anatomical Locations of 
Skin Disease in Psoriasis and Eczema Groups 
skincond = 1 skincond = 2 
location 
skin condition 1 = Psoriasis 
location 
skin condition 2 = Eczema 
Location 
1 = emotive area 
2 = non -emotive 
3 = all over 
Table 5: Location of Skin Lesions for Psoriasis and Eczema Groups 




4 8 12 (18.75 %) 
Not Emotionally 
Charged Area 
14 4 18 (28.12 %) 
All over 21 13 34 (53.13 %) 
Total 39 25 64 (100 %) 
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3.2 HYPOTHESES FROM THE LITERATURE 
3.2.1 Hypothesis la 
Females will report reduced quality of life in comparison to males. Research 
examining quality of life in individuals with skin conditions has indicted that females 
tend to have greater impairment in quality of life than males. Scores for males and 
females are compared on two quality of life factors, psychosocial and activities for 
both skin conditions. Between groups t -tests were used to compare scores, as 
illustrated in Table 6. 













31.9 45.9 -2.30 62 <.05 
Results indicate that the differences between male and female on both the 
psychosocial and the activity based sub -scales of the Dermatology Quality of Life 
Scales are significant at the <.05 level. 
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3.2.2 Hypothesis lb 
Hypothesis lb predicts that females will report greater stigma experience than males, 
as reported by the Experience of Skin Complaints (EoSC) measure. As with quality 
of life measures, research suggests that females report greater stigmatisation, as a 
consequence of their skin condition, than males. Differences between males and 
females were examined by comparing the overall score and scores on the five factors 
of the Experience of Skin Complaints measure as reported in Table 7. 




t df Sig.(one- 
tailed) 
Total Score 64.9 69.8 -1.15 62 (NS) 
Self esteem 11.9 13.5 -1.53 62 (NS) 
Retreat 17.9 19.3 -.861 
Reject 14.6 15.68 -.731 62 (NS) 
Composure 13.4 14.35 -.774 62 (NS) 
Conceal 7.0 7.32 -.631 62 (NS) 
Results indicate that there is no significant difference between males and females, on 
any of the factors of the Experience of Skin Complaints measure. 
3.2.3 Hypothesis 2a 
Younger age is predicted to cause greater impairment in life quality for individuals 
with eczema and psoriasis. Researchers have suggested that individuals are most 
likely to be most affected by their skin condition in terms of life quality during 
adolescence and early adulthood. Consequently, subjects have been differentiated by 
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whether their skin condition started before or after they were twenty -five years old. 
Table 8 compares age at onset with psychosocial and activity quality of life factors. 
Table 8: T -tests between Younger and Older Age at Onset of Skin 
Condition with Dermatology Quality of Life Scales 
Mean Score 
<25 > =25 
t df Sig.(one- 
tailed) 
- Psychosocial 
Quality of Life 44.1 26.0 3.06 58 <.01 
Activity Quality of 
Life 42.6 27.5 2.45 58 <.05 
* Data is missing for four individuals on age at onset of skin condition. 
T -tests indicate that there is a significant difference between younger age ( <25 years) 
and older age ( >= 25years) at onset of skin condition, on both factors of the 
Dermatology Quality of Life Scales. Results suggest that earlier age at onset of skin 
condition leads to greater impairment in quality of life. 
Comparisons were also made between current age and length of time with a skin 
condition in participants scores on the Dermatology Quality of Life Scales. This 
analysis was carried out using Pearson's Correlations as shown in Tables 9 and 10. 
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Table 9: Correlations Comparing Age with Dermatology 





Psychosocial Quality of Life 64 -.309 <.01 
Activity Quality of Life 64 -.164 (NS) 
Table 10: Correlations Comparing Length of Time with Skin 





Psychosocial Quality of Life 60 .001 (NS) 
Activity Quality of Life 60 .081 (NS) 
* Data is missing for four individuals on length of time with skin condition. 
On the psychosocial sub -scale of the Dermatology Quality of Life Scales (DQLS), 
results indicate that there is a significant relationship with current age but not length 
of time with a skin condition. No significant correlations were found between 
current age and length of time with a skin condition in relation to the activity sub - 
scale of the DQLS. 
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To establish what contribution current age, age at onset and length of time with skin 
condition make to the prediction of quality of life, a multiple regression analysis was 
conducted. A summary of the results are presented below in Table 11 and 12. 
Table 11: Multiple Regression Summary for Age, Age at Onset and 
Length of Time with Skin Condition Associated with 
Dermatology Quality of Life 
Dependant Adjusted R 
variable R square F Sig. 
Psychosocial 
Quality of Life .357 .081 2.72 (NS) 
Activity .219 .048 .943 (NS) 
Quality of Life 
Table 12: Regression Analysis Coefficients for Age, Age at Onset and 
Length of Time with Skin Condition Associated with Dermatology 
Quality of Life 
Dependant 




Age .581 .264 (NS) 
Age at Onset -1.06 -.430 (NS) 




Age .532 .231 (NS) 
Age at Onset -.824 -.321 (NS) 
Length of time with -.465 -.249 (NS) 
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The results suggest that no particular variables contribute significantly to either 
factor on the Dermatology Quality of Life Scales. 
3.2.4 Hypothesis 2b 
As with quality of life measures, it is expected that younger current age and age at 
time of onset will predict greater stigma experience, as measured on the Experience 
of Skin Complaints (EoSC) questionnaire. Table 13 compares age at onset (either 
<25yrs or >= 25yrs) with total score on the EoSC and on the five factors of stigma 
experience. 
Table 13: T -tests to Compare Younger or Older Age at Onset of Skin 
Condition with Experience of Skin Complaints Measure 
Mean Scores 
<25 > =25 
t df Sig. 
Total Score 67.5 63.5 .971 58 (NS) 
Self esteem 13.2 11.2 1.771 58 (NS) 
Retreat 18.6 17.4 .710 58 (NS) 
Rejection 15.3 14.0 .899 58 (NS) 
Composure 13.5 13.8 -.230 58 (NS) 
Concealment 7.1 7.1 -.082 58 (NS) 
* Data is missing for four individuals on age at onset of skin condition. 
No significant differences were found between younger and older age at onset and 
scores on Experience of Skin Complaints measure. Comparisons were also made 
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between current age and length of time with a skin condition using Pearson's 
correlations, see Tables 14 and 15. 






Total Score 64 -.007 (NS) 
Self esteem 64 -.121 (NS) 
Retreat 64 .039 (NS) 
Rejection 64 .026 (NS) 
Composure 64 -.023 (NS) 
Concealment 64 .061 (NS) 
Table 15: Correlations Comparing Length of Time with Skin 





Total Score 60 .080 (NS) 
Self esteem 60 .104 (NS) 
Retreat 60 .104 (NS) 
Rejection 60 .141 (NS) 
Composure 60 -.176 (NS) 
Concealment 60 .136 (NS) 
* Data is missing for four individuals on length of time with skin condition. 
75 
RESULTS 
Results indicate that there is no significant relationship between current age and time 
with a skin condition on the Experience of Skin Complaints measure. 
As with hypothesis 2a, to establish what contribution current age, age at onset and 
length of time with skin condition make to the prediction of stigma experience a 
multiple regression analysis was conducted. A summary of the results are presented 
below in Table 16 and 17. 
Table 16: Multiple Regression Summary for Age, Age at Onset and 





square F Sig. 
Total Score Experience 
of Skin Complaints .085 -.046 .137 (NS) 
Table 17: Regression analysis coefficients Age, Age at Onset and 
Length of Time with Skin Condition Associated with Stigma 
Experience. 
Variables Beta t Sig. 
Age -.423 -.180 (NS) 
Age at onset .454 .173 (NS) 
Length of time 
with condition 
.415 .217 (NS) 
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3.2.5 Hypothesis 3 a. 
This hypothesis explores the relationship between anatomical location of skin disease 
and quality of life scores on the Dermatology Life Quality Index. Subjects were 
divided into three categories based on their skin condition. These categories were: 
1. Skin disease in emotive areas (hands, wrists and face) 
2. Skin disease in non -emotive areas (legs, trunk and arms) 
3. Skin disease all over the body (emotive and non -emotive areas) 
Due to the variation between the group sizes for the anatomical location of skin 
disease, non -parametric statistical analysis was used. The Kruskal- Wallis test was 
used to compare the relationship between anatomical location of skin disease and 
quality of life. 
Table 18: Kruskal- Wallis Test between Anatomical Location of Skin 
Disease and Dermatology Quality of Life 
Location N 
Mean 




Quality of Life 
Emotive 12 36.92 12.51 2 <.01 
Non -emotive 18 19.36 
All Over 34 37.9 
Total 64 
Activity 
Quality of Life 
Emotive 12 31.83 12.6 2 <.01 
Non -emotive 18 20.08 




Results suggest that there is a significant difference between the non -emotive and the 
two other groups (emotive and all over) on both sub -scales of the Dermatology 
Quality of Life Scales. 
3.2.6 Hypothesis 3 b. 
As mentioned above, most of the research literature has focused on skin severity as a 
potential predictor of stigmatisation in individuals with skin disease. Gupta et al. 
(1998) reported that the majority of individuals reporting stigma experience had skin 
lesions in socially visible areas and concluded that anatomical location was a better 
predictor of stigmatisation than overall skin severity. This hypothesis predicts that 
individuals with more visible skin disease will score higher on the Experience of 
Skin Complaints measure. As with hypothesis 3a, the relationship between 
anatomical location of skin disease and stigma experience was analysed using 
Kruskal-Wallis Test. The results are presented in Table 19. 
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Table 23: Kruskal- Wallis Test between Anatomical Location of Skin 
Disease and Experience of Skin Complaints 
Location N 
Mean 
Rank H df 
Asymp. 
Sig. 
Total Score Emotive 12 29.33 1.71 2 (NS) 
Non -emotive 18 29.22 
All Over 34 35.35 
Self esteem Emotive 12 34.33 9.23 2 .01 
Non -emotive 18 21.42 
All Over 34 37.72 
Retreat Emotive 12 31.63 3.06 2 (NS) 
Non -emotive 18 32.58 
All Over 34 32.76 
Rejection Emotive 12 25.17 .034 2 (NS) 
Non -emotive 18 37.56 
All Over 34 32.41 
Composure Emotive 12 33.67 3.21 2 (NS) 
Non -emotive 18 29.31 
All Over 34 33.78 
Concealment Emotive 12 33.67 .765 2 (NS) 
Non -emotive 18 29.31 
All Over 34 33.78 
Overall, the results do not support the hypothesis that greater visibility of skin 
condition leads to greater experience of stigma. The only significant result obtained 
indicates that significant difference on the self -esteem sub -scale. 
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3.2.7 Hypothesis 4 
The research literature, examining the use of coping mechanisms in stressful 
situations, has tended to suggest that those who adopt any active problem solving 
strategy will show less psychological impairment. This hypothesis is examined by 
simple correlations between scores on the COPE and individual psychosocial score 
on the Dermatology Quality of Life Scales. The data is treated as ordinal and 
analysed using Kendall's Tau Correlation Coefficient. 
Table 20: Correlations between Psychosocial Quality of Life and 
Specific Coping Strategies* 
N Kendall's Tau -b Significance 
Psychosocial Quality of Life 
Active Coping 64 -.075 (NS) 
Planning 64 .012 (NS) 
Instrumental Social Support 64 -.032 (NS) 
Emotional Social Support 64 .006 (NS) 
Suppression 64 .029 (NS) 
Religion 64 -.01 (NS) 
Positive Reinterpretation 64 -.66 (NS) 
Restraint 64 .111 (NS) 
Acceptance 64 -.183 (NS) 
Focus on and Vent Emotions 64 .454 <.05 
Denial 64 .129 (NS) 
Mental Disengagement 64 .334 <.05 
Behavioural Disengagement 64 .165 (NS) 
Alcohol and Drugs 64 .209 (NS) 
Humour 64 -.155 (NS) 
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* Results, in the above table, have been corrected for multiple tests of significance by 
dividing the .05 level of significance by the number of correlations carried out. 
Table 20 shows that there are significant correlations at the 0.05 level between 
psychosocial quality of life and two coping strategies; focusing on and venting of 
emotions, and mental disengagement. 
3.2.7 Hypothesis 5 
Being stigmatised, due to an individuals skin condition, is frequently mentioned in 
dermatology quality of life literature as one of the strongest predictors of impaired 
quality of life. Consequently, in this hypothesis, it is predicted that both 
psychosocial and activity -based quality of life measures will correlate with scores 
obtained on a measure of stigma experience (Experience of Skin Complaints). As in 
hypothesis 4, the data is treated as ordinal and analysed using Kendall's Tau 
Correlation Coefficient. Results are shown in Tables 21 and 22. 
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Table 21: Correlations between Psychosocial Quality of Life and Stigma 
Experience* 
N Kendall's Tau -b Sig. 
Psychosocial Quality of Life 
Total Stigma Experience 64 .434 <.05 
Self -esteem 64 .488 <.05 
Retreat 64 .391 <.05 
Rejection 64 .200 (NS) 
Composure 64 .300 <.05 
Concealment 64 .139 (NS) 
* Results have been corrected for multiple tests of significance by dividing the .05 
level of significance by the number of correlations carried out. 
Table 22: Correlations between Activity Based Quality of Life and 
Stigma Experience.* 
N Kendall's Tau -b Sig. (2- tailed) 
Activity Quality of Life 
Total Stigma Experience 64 .451 <.05 
Self -esteem 64 .429 <.05 
Retreat 64 .471 <.05 
Rejection 64 .232 (NS) 
Composure 64 .242 (NS) 
Concealment 64 .147 (NS) 
* Results have been corrected for multiple tests of significance by dividing the .05 
level of significance by the number of correlations carried out. 
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Results indicate that both psychosocial and activity -based quality of life scores 
correlate with total stigma experience and two factors of the Experience of Skin 
Complaints measure; self -esteem and retreat. The sub -scale for composure correlates 
with the psychosocial sub -scale but not the activity sub -scale. The retreat and 
concealment sub -scales on the Experience of Skin Complaints measure does not 
correlate with either factor of the Dermatology Quality of Life Scales. 
3.3 EXPERIMENTAL HYPOTHESIS 
3.3.1 Hypothesis 6 a 
In the current research literature, psoriasis and eczema are usually described together 
and few studies examining quality of life differentiate between them. Studies on 
dermatological quality of life often group psoriasis and eczema, along with acne, as 
the skin conditions in which the greatest degree of impairment in quality of life is 
reported. Consequently, in this study, it was expected that there would be no 
significant difference in the impairment of life quality as measured by the 
Dermatology Quality of Life Scales between the psoriasis and eczema groups in this 




Table 23: T -tests between Dermatology Quality of Life in Psoriasis 
Group and Eczema Groups 
Mean Scores 
Psoriasis Eczema 
t df Sig. 
Psychosocial score between 
psoriasis and eczema groups 40.7 37.7 .472 62 (NS) 
Activity score between 
psoriasis and eczema groups 41.3 36.3 .790 62 (NS) 
Results indicate that there is no significant difference between Dermatology Quality 
of Life Scales scores for participants with psoriasis and eczema. 
3.3.2 Hypothesis 6 b 
Most of the current research exploring stigmatisation, as a consequence of skin 
disease, has focused on individuals with psoriasis although it is assumed that 
individuals with eczema suffer similar experiences. Despite claims of the 
Experience of Skin Complaints measure to be applicable to all skin diseases, it was 
only tested on individuals with psoriasis. To examine if there was a difference in 
experience of stigma, as reported in this study, between groups t -tests were carried 
out, examining total stigma experience and individual factors for psoriasis and 
eczema subjects, as illustrated in Table 24. 
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Table 24: T -tests between Experience of Skin Complaints in the Psoriasis 
and Eczema Groups.* 
Mean Scores 
Psoriasis Eczema 
t df Sig. 
Total 
Stigmatisation 72.4 60.0 3.05 62 <.05 
Self -esteem 13.2 12.1 1.02 62 (NS) 
Retreat 20.0 16.5 2.17 62 (NS) 
Rejection 16.1 13.7 1.56 62 (NS) 
Composure 15.7 11.0 4.22 62 <.05 
Concealment 7.7 6.4 2.53 62 (NS) 
* Results have been corrected for multiple tests of significance by dividing the .05 
level of significance by the number oft -tests carried out. 
Results indicate that there is, in fact, significant differences between participants with 
psoriasis and eczema on total scores on the Experience of Skin Complaints (EoSC) 
measure. Of the sub -scales of the EoSC only the factor for composure shows a 
significant result between psoriasis and eczema participants. 
3.3.3 Hypothesis 7 
Ginsburg and Link (1993) suggested that an understanding is required of the coping 
mechanisms employed by individuals who feel stigmatised by their skin condition. 
This hypothesis predicts that stigma experience is modulated by coping mechanisms. 
To examine which coping mechanisms are predictive of stigma experience, a 
stepwise multiple regression analysis was conducted. Two factors on the COPE 
(alcohol /drugs and humour) were excluded from the regression analysis as these 
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factors were not included in the initial design and validation of the COPE 
questionnaire. Results are indicated in Table 25 and 26. 
Table 25: Multiple Regression Summary for Coping Mechanisms 




square F Sig. 
Total stigma 
score .400* .147 11.83 .001 
*Predictors: Behavioural Disengagement 
Stepwise Criteria: probability of F to enter <= .05 and probability of F to remove 
>= .10 . Variables excluded = active coping, planning, seeking instrumental social 
support, seeking emotional social support, suppression, religion, reinterpretation, 
restraint, acceptance, focus on and venting of emotions, denial and mental 
disengagement. 
Table 26: Regression Analysis Coefficients for Coping Mechanisms 
Associated with Stigma Experience 
Variables Beta t Sig. 
Behavioural Disengagement .400 3.44 .001 
Results from the multiple regression analysis suggest that behavioural disengagement 
is the most predictive of total stigmatisation score. 
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Due to the limited sample size in this study, multiple regression analysis of coping 
mechanisms associated with stigma experience for the psoriasis and eczema groups 
is not possible. Therefore, correlations between total scores on the Experience of 
Skin Complaints measure and COPE for each of the two groups were conducted 
using Kendall's Tau correlation coefficient. These correlations are reported in 
Tables 27 and 28. 
Table 27: Correlations between Total Stigma Experience and Coping 
Strategies for Psoriasis Group.* 
N Kendall's Tau -b Significance 
Total stigma experience 
Active Coping 39 -.06 (NS) 
Planning 39 .01 (NS) 
Instrumental Social Support 39 -.091 (NS) 
Emotional Social Support 39 .085 (NS) 
Suppression 39 .077 (NS) 
Religion 39 .183 (NS) 
Positive Reinterpretation 39 .033 (NS) 
Restraint 39 .172 (NS) 
Acceptance 39 .023 (NS) 
Focus on and Vent Emotions 39 .353 (NS) 
Denial 39 .188 (NS) 
Mental Disengagement 39 .341 (NS) 
Behavioural Disengagement 39 .260 (NS) 
Alcohol and Drugs 39 .198 (NS) 
Humour 39 .080 (NS) 
* Results have been corrected for multiple tests of sigmficance by dividing th e . 
level of significance by the number of correlations carried out. 
87 
RESULTS 
Table 28: Correlations between Total Stigma Experience and Coping 
Strategies for Eczema group.* 
N Kendall's Tau -b Significance 
Total stigma experience 
Active Coping 25 -.122 (NS) 
Planning 25 .096 (NS) 
Instrumental Social Support 25 -.0.92 (NS) 
Emotional Social Support 25 .032 (NS) 
Suppression 25 .035 (NS) 
Religion 25 -.262 (NS) 
Positive Reinterpretation 25 -.175 (NS) 
Restraint 25 .025 (NS) 
Acceptance 25 -.149 (NS) 
Focus on and Vent Emotions 25 .066 (NS) 
Denial 25 .268 (NS) 
Mental Disengagement 25 .164 (NS) 
Behavioural Disengagement 25 .158 (NS) 
Alcohol and Drugs 25 .528 <.05 
Humour 25 -.088 (NS) 
* Results have been corrected for multiple tests of significance by dividing the .05 
level of significance by the number of correlations carried out. 
Results indicate that there is no major difference between the coping strategies used 
by psoriasis participants, in comparison to eczema participants, in the modulation of 
stigma experience. The only significant result is that eczema participants are more 
likely to use alcohol and drugs as a means of coping with stigma. 
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3.4 QUALITATIVE ANALYSIS 
3.4.1 Participants 
Fifty of the individuals, initially approached in the main study, were asked if they 
wished to take part in a short interview after completion of the questionnaire 
measures. Of those who completed the questionnaires, twenty individuals offered to 
attend a short interview. Of these, ten either failed to attend the appointment 
arranged or cancelled due to unsuitable times or other commitments. Consequently, 
ten individuals were interviewed for this study. On completion of these ten 
interviews, it was decided not to interview any further participants as similar themes 
were emerging from the information gathered. Participants, who were inpatients, 
were mainly interviewed during their ward stay. One patient was interviewed in her 
own home following discharge. All outpatient subjects were interviewed in the 
Clinical Psychology Department of the hospital, where they were currently receiving 
treatment. Unfortunately, due to interference on the tape, one of the interviews could 
not be transcribed. Therefore, nine participants are included in this part of the study. 
A summary of the participants is given below in Table 29. 
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Table 29: Descriptive Information of Participants who Attended the 
Semi- Structured Interviews 






1 Male 70 Inpatient Psoriasis 59 
2 Male 46 Outpatient Psoriasis 9 
3 Male 45 Outpatient Psoriasis 27 
4 Female 45 Inpatient Eczema 14 
5 Male 70 Inpatient Eczema 50 
6 Female 17 Inpatient Eczema 0 
7 Female 53 Outpatient Psoriasis 50 
8 Female 37 Inpatient Psoriasis 20 
9 Male 24 Outpatient Eczema 15 
3.4.2 Researcher Bias 
As in all qualitative analysis, it is important to outline researcher bias before analysis 
of the data. In this study, researcher bias was directed towards skin conditions, their 
course and consequences, having a clear influence on psychological wellbeing. In 
addition, the bias that psychological stress can effect the course of a skin condition 
was also evident. 
3.4.3 Data Analysis 
Data was analysed using grounded theory techniques to identify specific themes 
taken from the existing literature on coping and stigmatisation. The main themes 
explored were taken from the research of Metz and Jemec (1996), and Taylor and 
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Buckwalter (1988). The main themes identified, which corresponded to the current 
literature, were split into three broad categories as outlined below in Figure 1. 
Figure 5: Main Categories Identified from Subject Interviews which 
Correspond to Current Literature 
Stigmatisation / Stressful Situations 
Ignorance of others / embarrassment in front of others 
Situations where skin is exposed 
The mess and expense (time and financial) of treatment 
Effects of stress on the course of the skin condition 





Problem Focused Coping 
Seek appropriate treatment 
Educate self about the skin disorder 
Educate others about the skin disorder 
Focus on other activities 
Examples for each of the main categories are given below. For each theme, subjects, 
who were coded as having mentioned the particular theme, are identified in brackets. 
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skin is exposed 
Mess and expense 
of treatment 
Effect of stress 
"You see people looking at you funnily sometimes and perhaps 
wondering what on earth is wrong with you." 
"A family friend thought my psoriasis was contagious. She 
used to keep a cup and plate separate for me to use. She thought 
if she used them she would catch it." (1,2,6,7,8,9) 
"When I'm on holiday I'll cover up to avoid people looking at 
my skin." 
"I hate wearing dark clothes in case the flakes of skin show up" 
(2,3,4,6,7,8,9) 
"Everything gets greasy and basically has to be laundered 
separately" 
"It is difficult to find the time to put on the medications and it is 
impossible to put the treatments on your back yourself" 
(2,4,5,9) 
"If I am upset about anything I know that it will make it worse" 
"I've been told that stress makes it worse but I haven't found 
that it does get any worse when I am stressed" (4,7,8,9) 
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Table 31: Examples from Transcripts Relating to Emotion Focused 
Coping 






"The most frustrating thing is that when it is all over your body 
you tend to shy away from relationships... sexual relationships." 
"I used to love swimming but there is no way I would go now." 
"I have to admit I do go out and drink a lot sometimes, to take 
my mind off it." (2,4,5,6,8,9) 
"You have to get out and get on with your life the best you can." 
"I've had it for so long now I think I have come to terms with it" 
"If I had filled in your questionnaires fifteen years ago the 
answers would have been quite different, no I think I've just 
come to accept it." (1,2,3,6,7,9) 
"I've seen how bad other people can be and I think thank God 
I'm not that bad" 
"You don't die from it a lot worse things can happen" 
"You are almost a fraud in here (hospital) because you are not 
ill as such." (2,5,7,9) 
"I'm lucky that I don't have it on my face...I would say it must 
be 100 times worse for a woman." 
"I've been fortunate that I've never had it on my face, it might 
have been different if it had been on my face." (2,3,4,5,7) 
"If you spot someone with psoriasis... it is like you are kindred 
spirits and have a good natter about it." 
"It is nice to speak to someone (hospital staff) who can 
understand what is the matter with you. They can appreciate 




Table 32: Examples from Transcripts Relating to Problem Focused 
Coping 





Focus on other 
activities 
"I'm used to using the creams and things because I know that I 
can keep it under control." 
"I've now got an open appointment so I can get it seen as soon 
as it flares up." (3,4,5) 
"I know myself that if I do something (referring to triggers to 
flare -ups) it is on my own head, it is me that has to suffer for it." 
(1,6) 
"I think they should talk about it more in schools and let them 
know what some folk have got to put up with." (1,2) 
"I've always got something to occupy myself with and take my 
mind off my psoriasis" (1,5) 
Not all the information gathered during the interviews neatly fitted into the above 
categories. Consequently, four further categories were identified these are described 
in Figure 6. 
Figure 6: Themes Generated from Subject Interviews 
1. Frustration at the unpredictability of the course of skin disease. 
2. Self -esteem 
3. Effect on significant others 
4. Positive cognitions 




Table 33: Examples of Transcripts Relating to Participant Generated 
Themes. 








"I see myself getting on, then another eruption happens which 
puts me back to square one" 
"Sometimes it is quite bad and I am doing all the right things 
and it doesn't clear up, that can be quite frustrating." 
"You feel wonderful when your skin clears, really clean. Then 
gradually you see little pinpricks coming back, that is really 
frustrating" 
"I have this fear that once this treatment is finished it is going to 
come back. I don't think I could handle that." (1,4,6,7,8,9) 
"It makes you feel like you are really dirty. You feel awful and 
you get so embarrassed." 
"Having it all these years, you sort of withdraw into yourself a 
bit." 
"I became quite anti -social for a time (when skin condition first 
developed)." (1,6,7,9) 
"I think it can really affect the family. It is like they have it as 
well." 
"I think I have been lucky my husband has accepted it. I don't 
know if I would have been as sympathetic if he had it." 
(2,3,7,8,9) 
"You've just got to ignore other people it is not worth getting 
worked up about." 
"The staff say think positive... I've been doing that all the time 
if I didn't I would be dead." (2,6,7) 
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3.4.3 Summary of Qualitative Data 
From the information given in the interviews, it is evident in this sample group that 
having psoriasis or eczema is something that they have learned to cope with. For 
others, having one of these skin conditions is a major frustration in their lives. In 
particular, frustration at the unpredictability of the course of the disease, avoidance 
of situations when the skin is exposed, and ignorance of others about skin conditions, 
are the most frequently reported themes in this study. 
3.5 SUMMARY OF RESULTS 
3.6.1 Comparisons with Previous Research 
The results of this study overall replicate earlier findings relating to gender, age and 
location of skin disease in quality of life and stigmatisation in dermatology Patients. 
Females appear to have impaired quality of life but similar stigma experience in 
comparison with males. Age appears to be a contributory factor in quality of life, 
only when participants are separated in to older and younger age groups. In relation 
to stigmatisation, no age factors are significant to stigma experience. There is only a 
significant difference between `emotive' anatomical locations and `non- emotive 
areas' on psychosocial quality of life, although subject numbers in these divisions are 
small. In correlations between psychosocial quality of life and coping mechanisms 
not all the items which correlate highly are active problem solving strategies as 
predicted. Finally, with the exception of concealment, stigma experience correlates 
with both psychosocial and activity based quality of life. 
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3.6.2 Differences between Psoriasis and Eczema 
As expected there are no differences between patients with eczema and psoriasis for 
quality of life. However, there appears to be a significant difference between 
stigmatisation experience in the two skin conditions. 
3.6.3 Links between Coping Mechanisms and Stigma Experience 
Multiple Regression analysis, examining stigma experience with coping mechanisms 
suggests that behavioural disengagement is the coping strategy most predictive of 
stigma experience. Only one coping strategy correlates with stigma experience for 
the eczema groups. There are no significant correlations for the psoriasis group. 
3.6.4 Qualitative Analysis 
A number of themes are identified from current research literature and generated 
from participant interviews. A surprisingly broad range of themes has been 
identified, given the general questions asked during the interviews. From this small 
sample group, the major themes which were identified were; frustration at the 
unpredictability of skin disease, the ignorance of others and the need for avoidance 
of stigmatisation by concealment of skin disease or withdrawal from activities. 
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CHAPTER 4 - DISCUSSION 
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4.1 GENERAL SUMMARY OF RESEARCH 
Ginsburg and Link (1989, 1993) suggested that their research on stigmatisation in 
psoriasis patients would benefit from exploration of the coping techniques used by 
psoriasis patients. The principal aim of the current study was to explore the 
relationship between stigmatisation and coping style. As there has been no research 
to date exploring these issues in individuals with eczema, subjects with this skin 
condition were included in the study. Stigmatisation has often been referred to as a 
factor in quality of life of dermatology patients. To allow greater comparison with 
previous research, the relationship between quality of life, stigma experience and 
coping style in individuals with psoriasis and eczema was also explored. As an 
adjunct to this study, nine volunteers attended for interview to give their personal 
experiences in relation to quality of life, stigma experience and how they cope with 
their skin condition. 
4.2 GENERAL FINDINGS 
The present study is comparable with previous research examining quality of life and 
stigmatisation in dermatology patients in relation to subject numbers, gender and age 
mix. The response rate for participants (70.3 per cent) is quite high for a 
questionnaire- based design. The rate is exceptionally high given the relatively 
lengthy measures used and that the majority of participants completed the measures 
in their own time and returned them at their next appointment. Most of the current 
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research examining stigma experience and quality of life in dermatology patients, has 
recruited consecutive inpatients and /or outpatients and response rates are not 
reported (Gupta et al. 1988; Ginsburg and Link, 1993). As mentioned in the 
introduction, there are few studies which directly compare the differences between 
individuals with psoriasis and eczema. Results in the current study suggest that the 
main difference between the psoriasis and eczema groups were the mean current age 
and mean age at onset of the skin condition, with the eczema group being 
significantly younger than the psoriasis group. These differences are attributable to 
different mean ages at onset for the two skin conditions. Onset of eczema mainly 
occurs in childhood (Herd et al., 1997), while psoriasis has a bimodal distribution 
with the first peak of onset during late adolescence and early adulthood and a second 
peak in late middle age (Klaber, 1992). Using the definitions for anatomical location 
of skin disease devised by Gupta et al. (1998), there appears to be some difference 
between the numbers of psoriasis and eczema sufferers with skin disease in non - 
emotive areas of their body, such as the back, chest and legs. More eczema sufferers 
report skin disease in emotive areas such as the face. However, as the majority of 
participants indicated that their skin disease was all over their bodies, it is difficult to 
establish if there is a statistically significant difference between participants with 
psoriasis and eczema. 
Interestingly, many participants welcomed the opportunity to discuss difficulties they 
have had with their skin condition, especially the opportunity to discuss their 
difficulties and frustrations at having a skin condition. As a whole, the dermatology 
patients were very enthusiastic about participating in this study and frequently 
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commented that they hoped such research would help others avoid the difficulties 
they had faced. In addition, many of the older participants expressed that their 
responses would have been much different when they were younger. They explained 
that they had now accepted their skin condition and had learned to cope with it. 
4.3 HYPOTHESES FROM THE LITERATURE 
4.3.1 Hypotheses la and lb - Gender differences will be evident in quality of 
life and stigma experience 
It was predicted that there would be a significant difference between scores obtained 
by males and females on the Dermatology Quality of Life Scales (DQLS). Results 
confirmed this hypothesis, with significant results reported on both sub -scales of the 
DQLS with females reporting greater impairment in quality of life. In development 
of the DQLS, Morgan et al. (1997) reported that the measure corresponded with 
previous research in reporting greater psychosocial impact of skin conditions in 
females than males. One of the earliest papers to review this gender difference was 
by Roenigk and Roenigk (1978), in a study of individuals with psoriasis. On all 
measures used in this study, females reported greater impairment than males, 
although the statistical significance was limited. The results relating to outdoor, 
leisure and social activities, which are similar to the activity sub -scale in this study, 
were not found to be significant. Inclusion of the eczema group in the current study 
makes such a direct comparison difficult. Other research has produced contrasting 
views. Fortune et al. (1987), in a study of quality of life in psoriasis patients, found 
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no gender differences in any of the quality of life measures used in the study. A 
similar study by Linnet and Jemec (1999), in individuals with atopic dermatitis, 
found no gender differences on the Dermatology Life Quality Index (Finlay and 
Khan, 1994). With such varied results, further research using larger sample sizes 
than in the studies mentioned is required to establish if there are differences between 
males and females in quality of life issues associated with having a skin condition. 
The second prediction, made in relation to this hypothesis, was that females would 
report greater stigma experience than males. For total score on the experience of 
Skin Complaints (EoSC) measure, and all sub -scales of the measure, no significant 
differences were found between males and females in this study. Unfortunately, 
none of the research papers examining stigmatisation in individuals with skin 
conditions have compared the results given by males and females. Others have 
anecdotally suggested that stressful situations, such as being stigmatised, may be 
greater for women, when a cosmetically disfiguring condition can result in social 
disapproval (Jowett and Ryan, 1985). In a study examining illness -related stress, 
including stigmatisation in individuals with psoriasis, Fortune et al. (1997) 
concluded that women were more likely to experience stress in stigmatising 
situations that involved rejection. In the current study there is no significant 
difference for males and females on the rejection factor of the EoSC measure. From 
the qualitative data collected in this study, it was interesting that several male 
subjects commented that they thought "it must be 100 times worse for a woman ", but 
this was not reflected in the quantitative analysis with the Experience of Skin 
Complaints measure. These non -significant results may reflect the greater emphasis 
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in the EoSC measure on personal opinion of stigmatisation in skin conditions, rather 
than personal experience. Further research in this area could perhaps clarify 
differences, if any, in actual experiences of stigmatisation between males and 
females. 
4.3.2 Hypotheses 2a and 2b - Younger age groups will experience greater 
impairment in quality of life and greater stigma experience. 
It was predicted that the age of the participant, their age at the onset of the skin 
condition and length of time with skin conditions, would impact on quality of life 
and reported stigma experience. In examining the effect of age at onset on quality of 
life, subjects were divided into two groups, a younger group ( <25 years) and an older 
group ( >= 25 years). Results indicated that there was a significant difference 
between the younger and older groups on both the psychosocial and activity sub - 
scales of the Dermatology Quality of Life Scales (DQLS) measure. Although, the 
groups varied in size, (39 in the younger group and 21 in the older group), this 
reflects the general pattern that the majority of individuals will develop a skin 
condition before age 30 (Folks and Kinney, 1992). In the development of the DQLS, 
Morgan et al. (1997) reported that younger age was significantly associated with a 
higher psychosocial score. Unfortunately they do not report if there was any 
significant association with a higher activity score. Other authors report significant 
results between the younger and older groups on measures of psychosocial quality of 
life (Fortune et al. 1997a). The significant correlation between current age and 
psychosocial sub -scale of the DQLS add further support to the hypothesis. Non- 
significant results were found in comparing the relationship between the length of 
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time with skin condition for both factors of the DQLS. In a study of quality of life in 
psoriasis patients, Fortune et al., (1997b) reported similar findings, indicating that the 
duration of skin disease was unrelated to any area of quality of life. In a multiple 
regression analysis, results indicated that none of the variables relating to age, ages at 
onset or length of time skin condition, were predictive of dermatology quality of life. 
Similar comparisons were made between younger and older groups at age of onset in 
relation to the Experience of Skin Complaints measure (EoSC). Results showed 
there were no significant differences between the total score or any factors on the 
EoSC in the younger and older groups. These results contrast to those reported by 
Ginsburg and Link (1989). The authors reported that being older at onset of psoriasis 
protects individuals against anticipating rejection and being sensitive to the opinion 
of others, which is associated with stigmatisation. Non -significant results were also 
found in the current study, in examining the relationship between current age and 
stigma experience. In comparing length of time with skin condition and stigma 
experience, no significant relationships were found. These results contrast with 
previous research where longer duration of having the skin condition was associated 
with less guilt and shame, and less secretiveness (Ginsburg and Link, 1989). The 
experiences reflected in the qualitative analysis may correspond more to Ginsburg 
and Link's (1989) findings. Three of the older individuals interviewed suggested 
that their responses would have been quite different when they were younger, and as 
they had grown older they had been more accepting of their skin condition. As with 
quality of life, multiple regression analysis indicated that none of the variables 
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relating to age, age at onset or length of time skin condition, were predictive of 
experience of stigma. 
In this study, there appears to be some effect of current age and age at onset on 
dermatology quality of life, but not stigma experience. With a significant difference 
in current age at age at onset between the psoriasis and eczema groups, caution is 
required in interpreting the results. Analysis of the two groups separately may have 
yielded quite different results. 
4.3.3 Hypothesis 3a and 3b - Greater visibility of skin disease will lead to 
poorer quality of life and greater stigma experience 
Research examining the importance of anatomical location of skin disease has been 
mixed. The majority of the research literature has tended to focus on severity of skin 
condition in examining differences on quality of life and stigma experience. Fortune 
et al. (1998) suggest that there is growing anecdotal evidence that clinical severity is 
not a good indicator of quality of life or psychosocial wellbeing. To examine this 
further, subjects in this study were categorised on the basis of the anatomical location 
of their skin condition. The categories used are based around Gupta et al. (1998) 
definition of emotional (`emotive') and non -emotional (`non- emotive') areas. A 
third category, `all over', including both emotional and non -emotional areas of skin 
disease was included in this study. Fortune et al., (1997b) describe similar definitions 
that correspond to socially visible or non -socially visible anatomical locations. 
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Results indicated that there is a significant difference on both the psychosocial and 
activity sub -scales of the Dermatology Quality of Life Scales (DQLS). The results 
suggest that individuals with skin lesions in `non- emotive' areas, compared to 
`emotive' or `all over', report less psychosocial impairment. These findings compare 
favourably with previous research that reports social visibility of skin lesions to be 
associated with self -report of poorer physical health and to a lesser extent mental 
health (Fortune et al., 1997b). 
Similar analysis was conducted to examine the relationship between anatomical 
location of skin disease and experience of stigma. The only significant result 
reported is on the factor of the Experience of Skin Complaints measure (EoSC) 
related to self -esteem. Individuals with `non- emotive' areas of skin disease score 
significantly lower than the `emotive' and `all over' groups. Items on the self -esteem 
scale relate to issues such as feelings of worthlessness and feeling unclean. Perhaps 
those with skin conditions, that cannot be hidden from the view of others, are more 
likely to experience such feelings. Gupta et al. (1998), in a study exploring 
perceived deprivation of social touch in individuals with psoriasis, reported that all 
subjects who reported a stigma experience had at least one body region affected that 
was socially visible. An earlier study by the same research group, Gupta et al., 
(1989) reported disease -related stress to be significantly correlated in psoriasis 
patients with lesions in `emotionally -charged' body regions. Information collected in 
the qualitative analysis also relates to this hypothesis. Five of the subjects 
interviewed indicated that they felt lucky that they had never had their skin condition 
on their faces and that "it might have been different if I had it on my face ". 
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Interestingly, the four other subjects who were interviewed all had skin lesions on 
their face. One of these individuals commented, "if it was anywhere else on my 
body I could handle that, but when it is on my face or hands, it's the immediate 
contact that other people can see ". 
Overall, the numbers in the `emotive' and `non- emotive' groups are small. As the 
descriptions for `emotive' and non -emotive' areas have altered from the Gupta et al. 
(1989) paper it is impossible to add support to their findings. The results from the 
qualitative analysis however appear to support Gupta et al.'s concept that those with 
lesions in emotive areas experience greater difficulties. Future studies with a larger 
subject groups and clearer definitions of what constitutes `emotive' and `non - 
emotive' areas may yield more conclusive answers. 
4.3.4 Hypothesis 4 - Levels of psychosocial distress will be lower in individuals 
who adopt active problem solving approaches to coping 
In this study, active problem solving approaches to coping were measured using the 
COPE. To establish if there is a relationship between active coping and greater 
psychosocial quality of life, correlations were conducted between sub- scales of the 
COPE and the psychosocial sub -scale of the Dermatology Quality of Life Scales 
(DQLS). As mentioned in the introduction, Carver et al. (1989) suggest that active 
coping is similar to the core of Lazarus and Folkman's (1984) problem- focused 
coping, with the addition of several factors. These include `planning', `suppression 
of competing activities', `restraint coping', and `seeking social support for 
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instrumental reasons'. In this study, none of these factors showed a significant 
correlation with psychosocial quality of life. As the COPE was designed to examine 
coping strategies used in stressful situations, it is perhaps not as applicable to the 
long -term stresses faced by individuals with chronic illness. 
As Schüssler (1992) suggests, the course of chronic disease is not only determined 
by biomedical or genetic factors but also by the way, the patient deals with his or her 
illness. Hence, Patient's coping capabilities mediate between the disease and its 
psychosocial effects. Psychological problems mainly arise in patients with 
insufficient coping capabilities (Metz and Jemec, 1996). Many authors have 
suggested that emotion -focused coping frequently occurs in individuals who do not 
accept their illness or feel unable to control it. In contrast, those who use problem - 
focused approaches have a better outcome (Felton et al., 1984; Aldwin and 
Revenson, 1987; Schüssler, Certainly, this study, there appears to be a 
relationship between emotion- focused coping and greater psychosocial impairment. 
The only significant relationships found are on two factors, focusing on and venting 
emotions and mental disengagement. This suggests that participants who use these 
dysfunctional coping mechanisms expressed greater psychological impairment as 
measured by the DQLS. Overall, caution must be observed in interpretation of these 
results, as the psychosocial sub -scale of the DQLS, although validated, is a rather 
broad means of measuring psychological impairment. To allow comparison with the 
extensive literature examining anxiety and depression, in psoriasis and eczema, use 
of standardised anxiety and depression measures could have been used. Future 
studies could perhaps use these standardised measures to indicate relationship with 
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coping strategies. It may also be advantageous to compare coping with general 
every-day stresses with the situational stresses related to having a chronic skin 
condition. The COPE would be an ideal measure for this as it allows comparison 
between dispositional and situational coping. 
4.3.5 Hypothesis 5 - Levels of psychosocial distress will be higher in 
individuals reporting greater stigma experience. 
As predicted, the results indicate that there is a significant relationship between both 
psychosocial and activity -based quality of life. In particular, there are significant 
correlations between total score on the Experience of Skin Complaints (EoSC) 
measure and both factors on the Dermatology Quality of Life Scales. The 
concealment factor does not correlate with either sub -scale of the Dermatology 
Quality of Life Scales (DQLS). This result is surprising, as concealment refers to 
tendencies to keep the skin condition a secret and hiding the diagnosis from others, 
which would be expected to have a considerable effect on quality of life. Ginsburg 
and Link (1993) identify secretiveness as one of the main outcomes of stigma 
experience. Qualitative analysis of the semi -structured interviews suggested that 
concealment of the skin condition through avoidance of the skin being exposed, 
through avoidance of activities, and through wearing concealing clothing are 
frequent responses. This non -significant result could in part be explained by 
methodological issues associated with the EoSC measure. The factor concealment 
consists of only four items, whereas other factors on the scale consist of between six 
and nine items. In addition, modification of the scoring scale, by including a 
midpoint of `not sure', may have restricted scoring on this smaller factor. Both 
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retreat and self -esteem significantly correlate with both sub -scales of the DQLS. The 
retreat factor relates to outer appearance and situations that lead to avoidance of 
stigmatisation. It may be that this factor is more representative of Ginsburg and 
Link's factor of secretiveness. The rejection factor, which was not significant for 
both psychosocial and activity based quality of life, taps items relating to anticipated 
or expected rejection from others. This result contradicts the Ginsburg and Link 
(1993) study, when they reported high correlation between anticipation of rejection 
and quality of life issues, such as problems at home and work and avoidance of 
public places, as a consequence of having a skin disease. Although their study 
focused on acts of outward rejection, both Ginsburg and Link (1993) and Gupta et al. 
(1998) acknowledge that subtle rejection can be just as detrimental to an individual's 
quality of life. From the semi - structured interviews, it was noted that avoidance of 
situations, where the individual may feel stigmatised by their skin condition, was one 
of the most frequently reported items. These experiences were evident amongst 
some participants in the main study as well. One female with psoriasis noted her 
feelings about being stigmatised by her skin condition. Following completion of the 
EoSC measure, she wrote; 
"My skin condition is hereditary, I accept that, but at the same time I feel why 
me, when there are three siblings and I am the only one to have it. At the 
same time I would not wish it on any of my sisters. Psoriasis is, and always 
has been. the bain of my life. Right from childhood through to adulthood I 
have been ridiculed, avoided, shunned, laughed at, right down to people 
openly going ugh to your face. I hate it and I feel for my husband who does 
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not have psoriasis but still has to suffer because of it. I do pray not for myself 
but for my children that they do not inherit that!" 
These results indicate that there is a significant link between stigmatisation and 
impaired quality of life in individuals with psoriasis and eczema. 
4.4 EXPERIMENTAL HYPOTHESES 
4.4.1 Hypotheses 6a and 6b - Psoriasis and Eczema Patients will report similar 
levels of stigma experience and quality of life 
It was predicted that there would be no difference between psoriasis and eczema 
patients in dermatological measures of quality of life. Much of the current research 
examines eczema and psoriasis separately or groups them together with other skin 
conditions. There has been no research to date exclusively comparing quality of life 
in the two conditions. However, the course, treatment and problems faced by 
psoriasis and eczema sufferers are often seen as very similar, thus prompting the lack 
of distinction in quality of life research. In this study, it was reported that there is no 
significant difference between psoriasis and eczema subjects on both factors of the 
Dermatology Quality of Life Scales. Interestingly in the development of the 
Dermatology Quality of Life Scales, Morgan et al. (1997) report a difference in mean 
scores between Psoriasis and Eczema subjects on both factors of the questionnaire. 
Unfortunately, they do not report if these differences are statistically significant. 
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However, the small numbers of psoriasis patients (n =23) and eczema patients (n =18) 
in the Morgan et al. (1997) study may account for such differences. 
Although, the majority of research exploring stigmatisation in individuals with skin 
conditions has focused on individuals with psoriasis (Ginsburg and Link, 1989, 1993; 
Gupta et al. 1998), it was predicted in this study that individuals with eczema would 
face similar stigmatisation. However, the results indicate that there is a significant 
difference between the psoriasis and eczema groups on total scores on the experience 
of Skin Complaints measure. Non -significant results are reported on four of the 
measure sub -scales, self -esteem, retreat, rejection and concealment between the 
psoriasis and eczema groups. Consequently, the only factor that shows a significant 
difference between the psoriasis and eczema groups is composure. The differences 
in age of onset of skin disease and current age differences between the psoriasis and 
eczema groups could explain the significant differences on the total scores obtained. 
Perhaps early onset in eczema allows greater acceptance of means by which to cope 
with stigma associated with having a skin condition by the time an individual reaches 
adulthood. In addition, eczema is perhaps a less stigmatising condition, when it 
develops in childhood. As the National Eczema Society (1997) suggest that between 
5 and 15 percent of children experience eczema, it is relatively common and in 
general has a higher profile then psoriasis. Another explanation maybe in relation to 
stress levels among individuals with a skin condition. Certainly, there has been 
greater interest in the role of stress in psoriasis, with suggestions that stress is a more 
significant feature of psoriasis, than it is of eczema. Perhaps the stress of 
stigmatisation is therefore greater in individuals with psoriasis than for those with 
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eczema. The factor on the EoSC measure, that shows a significant difference 
between the two groups, is composure. This factor reflects calmness and confidence 
in spite of having a skin disease. The results suggest that eczema participants show 
significantly more composure than psoriasis participants. Perhaps developing a skin 
condition at a younger age allows eczema patients to develop strategies for dealing 
with stigma. As psoriasis typically develops at a crucial developmental period, late 
adolescence and early adulthood, the individual with psoriasis may be more aware of 
stigmatisation and less able to deal with it. Gupta et al. (1989) noted that 58 percent 
of psoriasis patients develop their skin condition during this period of development, 
when we are most self -conscious of our appearance and the image we portray. 
Evidently this is only one suggestion and further investigation, perhaps comparing 
psoriasis and eczema subjects at this `critical period', is required. 
4.4.2 Hypothesis 7 - Stigma experience modulates coping. 
As mentioned earlier, Ginsburg and Link (1993) suggested that further research 
examining stigmatisation should explore the coping strategies employed by 
individuals to deal with this. In the current study, this hypothesis was analysed by 
comparing total score on the Experience of Skin Complaints measure and 13 items 
on the COPE. Using a stepwise regression analysis, the results suggest that the only 
factor on the COPE which is predictive of total stigma score is behavioural 
disengagement. Behavioural disengagement, as defined by Carver et al. (1989), 
refers to the individual reducing their effort to deal with a stressful situation and in 
effect giving up. Theoretically, behavioural disengagement is most likely to occur 
when the individual expects poor coping outcomes. Carver et al. (1989) compare this 
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phenomenon to the literature on learned helplessness. This result perhaps suggests 
that individuals with a skin condition who experience stigma are most likely to cope 
with this stigmatisation by giving up in their attempts to effectively deal with the 
problem of stigmatisation. However, in individuals with chronic illness where active 
steps will not cure their condition, behavioural disengagement may actually be an 
effective way to deal with the difficulties associated with stigmatisation. Fortune et 
al. (1997a) suggest that individuals with diseases with an unpredictable course, as 
with psoriasis and eczema, display dominant avoidance strategies targeted at 
suppressing anxiety and depression associated with insecurities about the future. 
This would imply overlap with the factor relating to acceptance, which has not been 
found to be significant in this study. Despite this speculation, behavioural 
disengagement accounts for only a small percentage of the variance in relation to 
sigma experience and more detailed research is required to further establish the 
relationship between stigmatisation and coping styles. 
Due to the limited number of participants in this study, a similar multiple regression 
analysis examining the relationship between stigma and coping in the psoriasis and 
eczema groups was not possible. To examine the relationship between stigma 
experience and coping for each group, Kendall's Tau correlations were conducted. 
The results suggest that there is not any major difference between the coping 
mechanisms used by each group in relation to stigma experience. Only one factor 
significantly correlates with stigma experience in the eczema group, alcohol and 
drugs. Although the factor of alcohol and drugs on the COPE was not initially 
validated, it is interesting that this should be associated with greater stigma 
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experience in individuals with eczema. There is certainly a lack of research 
comparing alcohol use in individuals with skin conditions, although anecdotal 
evidence suggests alcohol use is increased in psoriasis patients compared to other 
groups of individuals with chronic illness. Hughes et al., (1983) suggested that 
alcohol is commonly abused by individuals as a means of controlling the pain and 
itching associated with having a skin condition. It could be speculated that the 
eczema patients in this study experience greater pain and itching associated with 
their skin disease. As it was suggested earlier, individuals using certain emotion - 
focused coping techniques are more likely to report greater stigma experience. As 
much of the coping research suggests that emotion -focused coping is maladaptive, 
the current results appear to support this proposition, in that emotion -focused coping 
(behavioural disengagement) relates to greater stigma experience. Further research is 
perhaps required to establish if some forms of emotion -focused coping are in fact 
adaptive for those individuals faced with the stresses that accompany having a 
chronic illness. 
4.5 QUALITATIVE ANALYSIS 
4.5.1 Discussion of Findings 
The aim of the qualitative analysis in this study was to report the diversity of 
experiences with everyday problems and feelings of stigmatisation, endured by 
individuals with psoriasis and eczema. It was also hoped to explore the coping 
strategies used by individuals to deal with their chronic illness. As discussed further 
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in section 4.5.2, given the small numbers involved in this part of the current study, no 
claim is made that the opinions expressed statistically represent the experience of 
psoriasis and eczema patients in general. There have been very few studies using 
qualitative methods to explore the problems associated with having a chronic skin 
condition. Taylor and Buckwalter (1998), as an adjunct to a coping questionnaire, 
asked open -ended questions relating to how individuals with psoriasis coped with 
their skin condition. The specific themes identified in the Taylor and Buckwalter 
(1988), study and specific categories from the general coping literature, have been 
used to inform theme generation in the current study. Additional themes relating to 
the stigma experience have been based on the main research studies examining 
stigma experience in psoriasis patients (Ginsburg and Link, 1989, 1993; Gupta et al. 
1989, 1998). 
The first set of themes, identified from the transcripts, relate to stigma experience 
and stressful situations. Four main themes were identified; ignorance of others, 
situations relating to skin exposure, the messiness and expense of treatment regimes 
and the effects of stress on the course of the skin condition. Ignorance of other 
individuals and situations relating to exposure appear to be interrelated. The 
majority of the participants interviewed could mention at least one situation where 
they had been upset by the comments or looks from others about their skin condition. 
Fortune et al., (1997b) commented that stress, resulting from anticipating other 
people's reactions to their psoriasis, contributed more to the variance in patients' 
disability in everyday life than any other medical or health status variable. These 
situations were not always overt, as with the situations described by Ginsburg and 
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Link (1989); Gupta et al., (1998). Many referred to glances from strangers and 
unwanted questioning about their skin. As a consequence, several participants 
reported that they tended to cover -up the affected areas whenever possible. This 
appeared to be of greatest frustration on holiday, with many reporting that they felt 
uncomfortable wearing shorts and tee -shirts and would avoid this whenever possible. 
The shedding of skin is a particularly frustrating aspect of having a skin condition. 
Several participants indicated that they avoided wearing dark clothes and were 
conscious in the company of others to avoid sitting in chairs where any flakes of skin 
left behind would be noticed. Such issues are a constant reminder for individuals 
with psoriasis and eczema that they have a chronic skin condition. This is also 
reflected in the messiness of treatment. Several subjects commented on the problems 
associated with the greasy emollients used to control their condition. Other problems 
relate to the side effects of treatment. Those using steroid creams fear thinning of the 
skin in later life, while those receiving light treatment incur a higher risk of 
developing skin cancer. It appears that, on top of the daily stresses associated with 
having a skin condition, there is the added worry the treatments to control the 
condition may result in other problems later. In relation to the effect of stress on skin 
condition, surprisingly few participants indicated awareness that stress made their 
condition worse. This is interesting given the vast amount of literature exploring the 
role of stress in the onset and maintenance of both psoriasis and eczema. As 
Ginsburg and Link (1993) suggest that perhaps the individual is unaware of the 
subtle life stresses that can effect their skin condition. 
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The second category of themes relates to emotion -focused coping. Five themes, 
broadly relating to emotion -focused, were found. These relate to emotion -focused 
coping identified by Taylor and Buckwalter (1988) and Carver et al., (1989). These 
are; avoidance, acceptance, minimisation, feeling lucky and seeking emotional 
support. Other coping strategies identified in the literature were not found in the 
participant's transcripts, such as venting of emotions (anger) or use of religion, 
alcohol or drugs. However, the themes identified are probably restricted by the types 
of questions asked in the semi- structured interviews. Avoidance and acceptance 
appear to be the main emotion -focused coping strategies used by this subject group. 
Clearly, there is some degree of overlap with the previous theme relating to 
situations where the skin is exposed with general avoidance. Avoidance of activities, 
such as swimming, appears to be common as a means of avoiding exposure and 
subsequent embarrassment. Two participants suggested that swimming pools should 
hold special evenings for sufferers of skin disease to avoid embarrassment and 
unwanted stares. Acceptance of having a skin condition, and coming to terms with 
it, is also a common coping strategy in this group. With the prospect of having a life- 
long condition with an unpredictable course, this is perhaps the most effective 
strategy for dealing with the problems associated with a chronic skin condition. 
Interestingly this was not reflected in the main study, comparing acceptance with 
psychosocial impairment. Acceptance appears to be linked with two other themes 
identified, minimisation and feeling lucky. Several individuals identified that they 
felt a fraud and did not really view themselves as ill and those who had never had 
lesions on their face felt very fortunate. Feeling a fraud was especially common 
among the hospitalised subjects, who found it difficult to justify a four -week stay in 
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hospital for "just a skin problem ". The fifth theme identified relates to seeking social 
support. Many of the participants appeared to feel isolated by their condition. The 
opportunity to speak to other sufferers or hospital staff, who "can understand what is 
the matter with you ", is greatly appreciated. It is possible that such day to day 
isolation in the community can contribute to disease -related stress. 
In comparison to emotion -focused coping, problem- focused coping strategies were 
less frequently reported by the participants. Again, this may be related to the limited 
questions asked in the semi -structured interviews. Four themes were identified in 
relation to this category; seeking appropriate treatment, educating oneself about the 
skin condition, educating others and focusing on other activities. The most 
frequently reported coping method was seeking appropriate treatment, which 
corresponds to results reported in the Taylor and Buckwalter (1988) study. Most 
subjects recognised that, when they could no longer control their symptoms 
themselves, contacting their dermatologist was the most appropriate course of action. 
Others recognised the need to educate others about having a skin condition and 
taking positive action to change the misconceptions of others. The lack of problem - 
focused coping reflects the results found in the quantitative analysis and poses the 
question whether the term problem- focused or active coping is appropriate, when the 
stressor, the chronic skin condition, can not be removed. 
Some of the issues discussed by participants in the interviews did not quite fit with 
the themes identified above. Consequently, an additional category was generated 
from the participants comments. The main themes identified were frustration at the 
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unpredictability of skin condition, self -esteem, the effect on significant others(family 
and friends) and positive cognitions(viewing their skin condition as positive). The 
most frequently reported of these themes was the frustration at the unpredictability of 
psoriasis and eczema. Although many of the treatments hold out great promise of a 
cure, in reality the majority of patients only receive a brief remission from their 
symptoms. One may speculate that this contributes to the high rates of depression 
reported to occur in individuals with skin complaints (Gupta and Gupta, 1998). In 
addition, this unpredictability may hamper the use of problem- focused coping, if the 
stressor is only going to reappear again. Comments in the transcripts, which relate to 
the theme of self -esteem, reflect the devastating effect a skin condition can have for 
some individuals. Participants referred to "withdrawing into themselves ", "being 
anti -social" and "feeling awful and embarrassed ". Such opinions link with the 
extensive literature discussed earlier, reporting increased psychosocial difficulties for 
individuals with psoriasis and eczema when compared to controls. Interestingly, the 
third theme exploring the effect on significant others is not something that is 
extensively reported in the literature. There is some research relating to the 
difficulties that families of children with severe eczema experience, but not about the 
effects of adults having a skin disease. Families of adults with skin disease may have 
to help with treatment regimes, will certainly be aware of the messiness of some 
treatment and, for those who need frequent hospital treatment, endure long periods 
time when their relative is in hospital. The final theme identified, positive 
cognitions, could perhaps be classed as an effective coping strategy. These 
participants emphasised the importance of being positive to help cope with their skin 
condition. One participant, who had been hospitalised for four months when 
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interviewed, commented that if he had not been positive he thought he would have 
been dead by now. 
Clearly not all the comments made during the interviews could be categorised into 
the main themes given above. Those that have been identified demonstrate the 
extent to which both psoriasis and eczema can have a devastating effect on 
psychosocial wellbeing. Although many individuals with these skin conditions cope 
admirably with their disability, for others day -to -day coping is more difficult. 
Several authors have suggested the need for psychological therapy to enhance the 
sufferers sense of control over their skin condition and effectively manage the 
associated stresses, in particular stigmatisation (Taylor and Buckwalter, 1988; 
Ginsburg, 1996 and Metz & Jemec, 1996). Unfortunately as reviewed in the 
introduction, there has been limited development of psychological therapies for 
dermatology patients. 
4.5.2 Methodological issues relating to qualitative analysis 
Interpretation of qualitative data collected in this study is bounded by the fact that the 
analysis did not strictly adhere to any specific qualitative approach. The analysis 
was based around grounded theoretical methods as described by Henwood and 
Pidgeon (1995). In an attempt to link qualitative and quantitative paradigms, 
interpretation of the transcript information may have been compromised. This is 
particularly evident from the identification of themes from previous research rather 
than the themes being solely derived from the data. Despite the frequency with 
which the identified themes are reported by the participants, it is not implied that 
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these are representative of the total subject population. This analysis, although rich 
in the information it provides, is only pertinent to the particular subject group. 
However the use of a semi - structured interview, with open -ended questions, allowed 
for a diverse picture of individual experiences of having to live with a chronic skin 
condition, which are often missed in questionnaire methods. Obviously, the use of 
this format of interview imposes some constraints that could have been avoided by 
using depth interviewing, where the interviewee directs the structure of the interview. 
Analysis of the data was conducted by coding of the transcripts by the researcher. 
Coding of the transcripts could have been improved by the use of a more formal 
method of identifying themes, such as construct analysis. The analysis process could 
have been further enhanced by inter -rater reliability, with a second researcher re- 
coding the transcripts and minimising researcher bias. In addition, the transcripts 
tended to focus on individual experience, and the opportunity to find out about 
participants' opinions of their skin condition in general, may have further enriched 
the analysis. 
Sample selection for this qualitative analysis was restricted by the time constraints of 
the research. Consequently, information may have been lost by only asking the first 
fifty participants if they wished to volunteer to take part in an interview. This was 
evident throughout the research period, as many of the participants in the main study 
supplemented the information provide by the questionnaire method. This was 
usually noted by comments attached to the questionnaires or directly approaching the 
researcher and offering to participate further in the research if required. 
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4.6 GENERAL METHODOLOGICAL ISSUES 
Methodological issues relating to the qualitative analysis have already been 
discussed above. In relation to the general methodological issues, there are several 
points that warrant further discussion and have implications for the interpretation of 
the results. One of the main difficulties was the lack of a measure of skin severity. 
As discussed earlier, there is a lack of consensus over effective means of measuring 
severity of skin disease. In addition, the time constraints, and recruitment of 
participants at different points in their treatment, made measurement of severity in 
this study an impossible task. Many of the subjects who participated in the study 
were receiving light treatment and for many at the end of their treatment they were 
virtually clear of any skin lesions. Consequently, separating the subjects on the basis 
of the anatomical location of their skin conditions was potentially not the most 
reliable method of distinguishing between individuals. In reality, no individual 
indicated that they no longer had any skin lesions. Thus, they probably indicated the 
anatomical location in which their skin condition usually appears. Consequently, it 
may have been advantageous to record current method of treatment and stage in 
treatment as additional variables. 
In the initial stages of this study, it was hoped to allow further comparisons between 
inpatients and outpatient with psoriasis and eczema. Unfortunately, the number of 
inpatients who participated in the study was minimal. In the early stages of data 
collection, a influenza epidemic limited the number of beds available for psoriasis 
and eczema patients in the dermatology ward. As much of the current literature 
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includes inpatients and outpatients within the same subject groups, the collapsing of 
the subject groups in this study was not expected to compromise results. 
Power calculations suggested that 30 participants were required in both the psoriasis 
and eczema groups to produce a large effect size for the statistical analysis used. 
Larger numbers of individuals with psoriasis receive light therapy as a treatment 
method, than eczema sufferers. As patients who receive light therapy were the most 
accessible in recruitment of subjects, there is a wide variation in the number of 
subjects in each group, 39 in the psoriasis group and 25 in the eczema group. A 
larger and more equal sample size may have resulted in additional, more robust 
findings. 
Another area of this study, that warrants further discussion, is the problem associated 
with the questionnaire methods used. Although the Experience of Skin Complaints 
measure claims to be equally applicable for use with all skin conditions, the authors 
only tested it on individuals with psoriasis. As reported earlier, the measure was 
adapted for use in this study, through modification of the scoring scale to include a 
neutral option. Although this is a possible improvement to the scoring, it limits the 
range of potential scores on each factor. As discussed earlier, one factor on the 
measure consists of only four items compared to six to nine items on other factors. 
With the addition of a neutral scoring option, this increases the potential for a floor 
effect in the reported results. Many of the participants indicated that they found the 
questions on this measure complicated. Consequently, there is a high probability that 
false positive responses have been obtained. They also commented on the repetitive 
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nature and excessive length of the COPE measure. Participants reported difficulties 
with the questions relating to the sub -scales for alcohol and drugs, religion and 
humour where there is very little variation in the four questions corresponding to 
each factor. Perhaps the difficulties in the comprehension and completion of these 
two measures restricted the number of participants who actually completed and 
returned the measures. In addition, the difficulties with these measures are evident in 
those participants who were excluded from this study, the majority for non - 
completion of the COPE or Experience of Skin Complaints measure. 
4.7 FUTURE STUDIES 
Suggestions for future studies in relation to the hypotheses outlined have been 
expanded on, where appropriate, throughout the discussion. Ideas for more extensive 
studies are discussed below. 
Initially, it was hoped to compare the difference between inpatients and outpatients 
in relation to stigmatisation, quality of life and coping mechanisms. Previous 
research has tentatively suggested that hospitalised groups have lower anxiety and 
depression than outpatients (Hashiro and Okumura, 1997) and that those in hospital 
report feeling less stigmatised by their skin condition (Ginsburg and Link, 1993). 
Others have suggested that psychosocial problems are actually greater for the 
hospitalised patient (Polenghi et al., 1994 and Mazzetti et al., 1994). Restricted 
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subject numbers in the current study prevented such a comparison, but it is clear that 
further research is required to clarify these differences. 
As mentioned earlier, many of the studies quantifying psychosocial impairment in 
individuals with psoriasis and eczema have suggested the need for psychological 
input to become standard in dermatological treatment. To date, research in this area 
has been limited and at times vague. Many of the participants who were interviewed 
and those who just completed the questionnaire methods welcomed the opportunity 
to discuss their difficulties and wished more was on offer to help them cope with the 
non -clinical aspects of their skin condition. The use of cognitive -behavioural 
techniques appear to be highly relevant to the problems discussed by the participants, 
yet only a handful of papers have been published using these techniques with 
dermatology patients. This is an obvious area where further research would be 
beneficial. 
4.8 CONCLUSIONS 
Psychological research in dermatology is still in its infancy. The response of the 
participants in this study was overwhelming, in terms of their enthusiasm to 
participate and their eagerness to discuss the difficulties they had faced as a 
consequence of their skin condition. The extent of psychosocial impairment and 
experience of stigma was greater than expected, very few reported that they had 
experienced no problems due to their skin condition. The results of this study 
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indicated that individuals with psoriasis and eczema have similar levels of 
psychosocial impairment, but psoriasis sufferers experience greater stigmatisation. 
Coping mechanisms do not appear to greatly influence stigma experience. In 
general, much of research has focused on quantifying the extent of psychosocial 
impairment and further work is needed to explore effective methods of helping 
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We are interested in your everyday experiences of having a chronic skin condition. 
Below are a number of statements, which relate to having a skin condition. 
Read each statement and circle the number which comes closest to how you feel 








1 2 3 4 5 
1 I have told people close to me to keep the fact of my skin a secret 1 2 3 4 5 
2 Many people assume that having a skin disease as I do is a sign of 
personal weakness. 1 2 3 4 5 
3 I often think that others think that patients with a skin disease are 
`dirty'. 
1 2 3 4 5 
4 I sometimes think that family members feel that I am weaker 
because I have a skin disease and they do not. 1 2 3 4 5 
5 If I thought an employer would discriminate against someone 
because of a skin disease like mine, I would not apply for the job. 1 2 3 4 5 
6 When my skin disease is severe, I am too ashamed to engage in 
sexual activity. 1 2 3 4 5 
7 If my child developed such a skin disease too, I feel he or she could 
have as good a life as if he or she did not have it. 1 2 3 4 5 
8 I do my best to keep family members I do not live with from 
hearing anything about my disease 1 2 3 4 5 
9 I do not mind when a family member is disturbed by the 
consequences of my disease (e.g. scales, smell of medicines or 
scratching) 
1 2 3 4 5 
10 If my child were to have the same skin disease as I, I think that he 
or she could develop his or her potential just as though he or she 
did not have it. 
1 2 3 4 5 
11 I rarely feel the need to hide the fact that I have my skin disease. 1 2 3 4 5 
12 When people learn that you have a skin disease like me, they begin 
to search for flaws in your personality 1 2 3 4 5 
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13 Patients with a skin disease are treated like lepers. 1 2 3 4 5 
14 I feel physically unattractive and sexually undesirable when my 
skin is bad. 1 2 3 4 5 
15 I never feel embarrassed or ashamed because of my skin disease. 1 2 3 4 5 
16 If my child were to develop such a skin disease, I would not feel 
guilty 1 2 3 4 5 
17 An employer who knows a person has a history of skin disease will 
probably pass over the application and give the job to someone 
else. 
1 2 3 4 5 
18 If I were to make a new friend, I would tell him or her all about my 
skin disease. 1 2 3 4 5 
19 Some people act as though my having my skin disease were my 
fault somehow. 1 2 3 4 5 
20 There are times when I feel `dirty', as though there is something 
deeply the matter with me, beyond the fact of my skin disease. 1 2 3 4 5 
21 People avoid me and shy away for fear that the skin rash is 
contagious. 1 2 3 4 5 
22 Having to use many creams and medications on the skin keeps the 
patient with a skin disease preoccupied with feeling unclean. 1 2 3 4 5 
23 If someone notices my sick skin and asks what it is I do not say that 
it is a skin disease. 1 2 3 4 5 
24 I would not apply or get training for a job that involved dealing 
with the public because of my skin disease. 1 2 3 4 5 
25 When my skin has broken out badly, there are times when I feel 
that life is not worth living. 1 2 3 4 5 
26 I often feel totally alone with my skin disease. 1 2 3 4 5 
27 I have that feeling that I am worth less than others 1 2 3 4 5 
28 I sometimes think I am rejected or treated with caution by others 
because of my skin. 1 2 3 4 5 
29 It is hard for me to admit that I have a skin disease. 1 2 3 4 5 
30 I have thought of committing suicide because of my skin disease. 1 2 3 4 5 
31 I try to dress in a manner that my skin disease is as unnoticeable as 
possible. 1 2 3 4 5 
32 Questions concerning my skin disease are embarrassing for me 1 2 3 4 5 
33 I do not go swimming or have a sauna because others could feel 
disgusted by my skin disease 1 2 3 4 5 
34 I have the feeling that others stare at my skin symptoms 1 2 3 4 5 
© Scmid -Ott, Jaeger, Kuensebeck, Ott and Lamprecht (1996). 
Reproduced with permission from the authors. 
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QUESTIONNAIRE FOR THE EXPERIENCE OF SKIN 
COMPLAINTS 
MODIFIED SCORING TO INCLUDE NEUTRAL MIDPOINT 
FACTORS SCORING 
1 Self -esteem 4 3 0 2 1 
2 Rejection 4 3 0 2 1 
3 Rejection 4 3 0 2 1 
4 Rejection 4 3 0 2 1 
5 Retreat 4 3 0 2 1 
6 Retreat 4 3 0 2 1 
7 Composure 1 2 0 3 4 
8 Concealment 4 3 0 2 1 
9 Composure 1 2 0 3 4 
10 Composure 1 2 0 3 4 
11 Composure 1 2 0 3 4 
12 Rejection 4 3 0 2 1 
13 Rejection 4 3 0 2 1 
14 Retreat 4 3 0 2 1 
15 Composure 1 2 0 3 4 
16 Composure 1 2 0 3 4 
17 Retreat 4 3 0 2 1 
18 Concealment 1 2 0 3 4 
19 Rejection 4 3 0 2 1 
20 Self -esteem 4 3 0 2 1 
21 Rejection 4 3 0 2 1 
22 Self -esteem 4 3 0 2 1 
23 Rejection 4 3 0 2 1 
24 Retreat 4 3 0 2 1 
25 Self -esteem 4 3 0 2 1 
26 Self -esteem 4 3 0 2 1 
27 Self -esteem 4 3 0 2 1 
28 Rejection 4 3 0 2 1 
29 Concealment 4 3 0 2 1 
30 Self -esteem 4 3 0 2 1 
31 Retreat 4 3 0 2 1 
32 Concealment 4 3 0 2 1 
33 Retreat 4 3 0 2 1 
34 Retreat 4 3 0 2 1 
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Date: Record Number: 
We are interested in how people respond when they confront difficulties in their lives, 
such as having a chronic skin condition. This questionnaire asks you to indicate 
what you generally do and feel about having a skin condition. 
Think about how you deal with your skin condition. Then respond to each of the 
following items by choosing one number for each, using the response choices listed 
just below. 
1 = I usually don't do this at all. 2 = I usually do this a little bit 
3 = I usually do this a medium amount 4 = I usually do this a lot 
Please answer every item. There are no 'right' or `wrong' answers, so choose the 
most accurate answer for YOU - not what you think 'most people' would say or do. 
1. I try to grow as a person as a result of the experience. 
2. I turn to work or other substitute activities to take my mind off things. 
3. I get upset and let my emotions out. 
4. I try to get advice from someone about what to do. 
5. I concentrate my efforts on doing something about it. 
6. I say to myself "this isn't real ". 
7. I put my trust in God. 
8. I laugh about the situation. 
9. I admit to myself that I can't deal with it, and give up trying. 
10. I restrain myself from doing anything too quickly. 
11. I discuss my feelings with someone. 
12. I use alcohol or drugs to make myself feel better. 
13. I get used to the idea that it happened. 
14. I talk to someone to find out more about the situation. 
15. I keep myself from getting distracted by other thoughts or activities. 
16. I daydream about things other than this. 
17. I get upset, and am really aware of it. 
18. I seek God's help. 
19. I make a plan of action. 
20. I make jokes about it. 
Li 
PLEASE Tv0.1 OvE2 
21. I accept that this has happened and that it can't 
be changed. 
22. I hold off doing anything about it until the situation 
permits. 
23. I try to get emotional support from friends and 
relatives. 
24. I just give up trying to reach my goal. 
25. I take additional action to try to get rid of the problem. 
26. I try to lose myself for a while by drinking alcohol or 
taking drugs. 
27. I refuse to believe that it has happened. 
28. I let my feelings out. 
29. I try to see it in a different light, to make it seem more positive. 
30. I talk to someone who could do something concrete about 
the problem. 
31. I sleep more than usual. 
32. I try to come up with a strategy about what to do. 
33. I focus on dealing with this problem and, if necessary, let other things 
slide a little. 
34. I get sympathy and understanding from someone. 
35. I drink alcohol or take drugs, in order to think about it less. 
36. I kid around about it. 
37. I give up the attempt to get what I want. 
38. I look for something good in what is happening. 
39. I think about how I might best handle the problem. 
40. I pretend that it hasn't really happened. 
41. I make sure not to make matters worse by acting too soon. 
42. I try hard to prevent other things from interfering with my efforts at dealing with this. 
43. I go to the cinema or watch television, to think about it less. 
44. I accept the reality of the fact that it happened. 
45. I ask people who have had similar experiences what they did. 
46. I feel a lot of emotional distress and I find myself expressing those feelings a lot. 
47. I take direct action to get around the problem. 
48. I try to find comfort in my religion. 
49. I force myself to wait for the right time to do something. 
50. I make fun of the situation. 
51. I reduce the amount of effort I'm putting into solving the problem. 
52. I talk to someone about how I feel. 
53. I use alcohol or drugs to help me get through it. 
54. I learn to live with it. 
55. I put aside other activities in order to concentrate on this. 
56. I think hard about what steps to take. 
57. I act as though it hasn't even happened. 
58. I do what has to be done, one step at a time. 
59. I learn something from the experience. 
60. I pray more than usual. 
LI 
n 
© The American Psychological Association, 1989. From 'Assessing coping strategies: a theoretically based approach', 
Journal of Personality and Social Psychology, 56, 267 -83. Reproduced with the kind permission of the authors and the 
publishers, the American Psychological Association. 
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APPENDIX 3 - DERMATOLOGY QUALITY OF LIFE 
SCALES 
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DERMATOLOGY QUALITY OF LIFE QUESTIONNAIRE 
This scale consists of a number of words that describe different feelings and 
emotions. Please read each item and then mark the appropriate answer in the 
box to indicate to what extent you generally feel this way about your skin 
roblem. 
very slightly 
or not at all 




;eorry about appearance 
feel distressed 
feel suicidal 
feel self conscious 
worry about what 
others think 
(eel short tempered 
feel lack of hope 
feel isolated 
feel lack of understanding 
from others 
feel dependent 




Worry about long - 
lErra effects 
Please indicate how much your skin problem generally affects or restricts ou 
in these things 
very slightly 







choice of clothes 
summer activities/ 
swimming 








©M.Morgan /R.J.Hay, 1996. Dermatology Quality of Life Scales (DQOLS) This must not be copied without the permission of the authors. 
Contact Dr Morgan, Dept of Public Health Medicine, UMDS, Guy's Campus, Capital House, Weston Street London, SE1 3QD 
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OUTPATIENT INSTRUCTION SHEET 
Thank you for agreeing to take part in this study. Before completing the 
questionnaires it would be helpful if you could provide the following information. 
NAME: 
DERMATOLOGY CONSULTANT: 
SKIN CONDITION (please tick): 
ECZEMA 
DATE OF BIRTH: 
PSORIASIS 
HOW LONG HAVE YOU HAD THIS SKIN CONDITION (in years)? 
WHICH SITES ON YOUR BODY ARE MOST AFFECTED? (please tick) 
a) Face / Head 
b) Hands / Wrists 
c) Chest / Abdomen / Back 
d) Arms / Legs and /or Feet 
e) All over 
n 
n 
1) Please complete the following three questionnaires. Ensure that you answer 
every question. 
2) If you wish to participate further in this research please read the attached letter 
and return the completed form with your questionnaires. 
3) Once you have completed the questionnaires please put them in the envelope 
with the information sheet and consent form. 
4) Return either by post or place in the box provided at the outpatient department. 
Thank you very much for your help. 
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INPATIENT INSTRUCTION SHEET 
Thank you for agreeing to take part in this study. Before completing the 
questionnaires it would be helpful if you could provide the following information. 
NAME: 
DERMATOLOGY CONSULTANT: 
SKIN CONDITION (please tick): 
ECZEMA 
DATE OF BIRTH: 
PSORIASIS 
HOW LONG HAVE YOU HAD THIS SKIN CONDITION (in years)? 
WHICH SITES ON YOUR BODY ARE MOST AFFECTED? (please tick) 
a) Face / Head 
b) Hands / Wrists 
c) Chest / Abdomen / Back 
d) Arms / Legs and /or Feet 
e) All over 
1) Please complete the following three questionnaires. Ensure that you answer 
every question. 
2) If you wish to participate further in this research please read the attached letter 
and return the completed form with your questionnaires. 
3) Once you have completed the questionnaires please put them in the envelope 
with this sheet and the consent form. 
4) Return to the researcher or ward staff. 
Thank you very much for your help. 
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Semi -Structured Interview Identifier 
Background Information 
Type of Skin Condition 
Length of time since onset 
Treatment 
Coping 
What do you find most frustrating about having eczema / psoriasis? 
What sort of things / situations make your eczema / psoriasis worse? 
What do you find most useful in helping you deal with your skin condition? 
Stigma Experience 
Have you ever experienced a situation where someone has made a conscious effort 
not to touch you because of your skin condition? 
If so, what? 
How did that make you feel? 
How did you respond? 




APPENDIX 6 - PARTICIPANT INFORMATION SHEET 
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PARTICIPANT INFORMATION SHEET 
We invite you to participate in a research project. We believe it to be of 
potential importance. However, before you decide whether or not to 
participate, we need to be sure that you understand firstly why we are doing it, 
and secondly what would be involved if you agreed. We are therefore providing 
you with the following information. Read it carefully and be sure to ask any 
questions you have, and, if you want, discuss it with outsiders. We will do our 
best to explain and to provide any further information you may ask for now or 
later. You do not have to make an immediate decision. 
1. The aim of this project is to find out about the problems you have to face as 
someone with eczema or psoriasis and how you are coping with this. 
2. If you agree to take part, you will be asked to complete a few questionnaires. 
This will take around 20 minutes. 
3. These can either be completed during your visit to the outpatient 
department or stay in the Dermatology ward. Alternatively you can take 
these home and return them in the reply -paid envelope provided. 
4. If you wish to participate further in this study and are willing to attend for a 
short interview please complete the attached form and return with your 
questionnaires. 
5. Anything you say will be treated in confidence and only the researchers will 
have access to the information provided. 
Participation in this study is entirely voluntary and you are free to refuse to take part 
or to withdraw from the study at any time without having to give a reason and 
without this affecting your future medical care or your relationship with medical staff 
looking after you. 
The * * * * * * * Committee on Medical Research Ethics that has responsibility for 
scrutinising all proposals for medical research on humans in * * * * * * has examined 
the proposal and has raised no objections from the point of view of medical ethics. 
(Research records may be examined by monitors from the Tayside Committee on 
Medical Research Ethics.) 
If you have any questions more information can be obtained from Lucy Kelman at 
the Clinical Psychology Department, * * * * * * * * * * * Hospital 
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Clinical Psychology Department 
Dear Patient 
You have already been kind enough to complete questionnaires in connection with 
the study looking at the problems people with skin diseases have. In addition to the 
questionnaires we are interested in your own personal experiences of the problems 
you have had to face as a result of your skin disease, and in looking at the different 
ways eczema and psoriasis sufferers cope with this. 
We are asking people who have completed the questionnaires if they would like to 
participate further in this study by attending an appointment at * * * * * * * * Hospital 
(or your own home if this is more convenient). This would be a one -off appointment 
and would last approximately 45 minutes. We would hope to arrange this interview 
within the next three weeks. Unfortunately, we would be unable to reimburse you 
for any travel expenses. 
If you are able to help us by attending, please complete the form below and return 
this with your questionnaires. If you would like any further information please 
contact Lucy Kelman 








Thursday Friday Any Day 
p.m. 
Any days that are not suitable within the next three weeks: 
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